Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AKR1C1 "DD1, DDH, DDH1, HAKRC, MBAB" ENSG00000187134 "Aldo-keto reductase family 1 member C1" Q04828 10 4963253-4983283 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 145.9;tongue: 74.5" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 239.5;Exocrine glandular cells: 290.3;Hepatocytes: 511.8" "Cancer enhanced" "Detected in many" "liver cancer: 64.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 8 "ASC diff: 185.8;Hep G2: 315.1;OE19: 134.5" "CAB047303, HPA068265" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "CAB047303: , HPA068265: AB_2685966" "unprognostic (1.54e-2)" "prognostic favorable (3.05e-4)" "unprognostic (4.04e-2)" "unprognostic (8.38e-2)" "unprognostic (3.18e-2)" "unprognostic (7.05e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (1.70e-1)" "unprognostic (1.63e-1)" "unprognostic (8.38e-2)" "unprognostic (4.65e-1)" "unprognostic (1.82e-2)" "prognostic favorable (8.03e-9)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (6.30e-2)" 52.0 3.8 2.1 3.4 4.1 1.4 36.0 2.6 2.7 2.2 3.2 2.6 1.2 6.2 1.4 4.0 19.2 1.7 16.1 22.1 2.6 2.6 32.0 145.9 11.2 2.5 5.4 1.4 3.8 4.9 0.6 4.1 0.7 6.6 5.1 3.2 3.8 13.1 3.4 17.1 4.7 4.6 4.8 6.8 0.9 21.9 5.2 3.2 0.0 11.5 74.5 5.0 17.4 10.8 0.0 0.9 4.2 0.1 0.3 1.7 0.8 0.0 25.5 0.1 25.7 185.8 22.4 0.0 0.8 5.7 0.3 0.2 0.4 0.0 0.0 0.3 5.7 4.4 0.2 0.0 1.3 0.1 0.0 0.0 0.7 4.1 315.1 1.8 0.1 0.0 11.4 1.6 2.6 1.6 0.0 0.6 0.1 5.4 0.0 4.4 0.1 0.0 0.0 0.0 134.5 0.0 0.0 0.0 0.2 1.4 4.8 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.4 5.0 2.2 0.1 5.9 0.2 0.1 0.0 0.0 7.9 0.7 0.0 4.2 0.1 1.1 1.7 0.0 0.1 0.0 0.7 0.4 0.2 0.0 0.3 1.5 0.9 0.3 0.0 0.9 0.4 0.8 2.1 4.1 2.6 2.7 2.6 2.6 5.4 1.4 6.6 3.2 62.5 27.2 1.5 11.8 18.8 2.5 2.4 239.5 96.4 128.5 59.3 0.0 0.0 11.6 33.9 14.9 17.8 9.3 70.0 290.3 0.0 13.4 11.4 4.6 511.8 0.3 0.0 1.7 26.4 14.5 8.0 140.4 3.8 101.3 8.2 1.7 47.9 184.6 0.9 138.6 40.8 4.3 0.0 14.4 1.7 0.7 17.9 0.1 0.9 2.6 140.8 ALB ENSG00000163631 Albumin P02768 4 73397114-73421412 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 81 "liver: 3075.8" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 49859.9" "Cancer enriched" "Detected in many" 384 "liver cancer: 14213.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Cell line enriched" "Detected in some" 39 "Hep G2: 315.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB006262, HPA031024, HPA031025" Enhanced Enhanced "Endoplasmic reticulum,Golgi apparatus" "Secreted to blood" NA NA 40000000000000 "Golgi apparatus" "Endoplasmic reticulum" "CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704" "unprognostic (1.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.73e-1)" "unprognostic (2.60e-1)" "unprognostic (4.44e-1)" "unprognostic (2.46e-1)" "unprognostic (9.53e-3)" "unprognostic (2.16e-2)" "unprognostic (2.40e-1)" "unprognostic (6.43e-2)" "unprognostic (3.84e-2)" "unprognostic (5.37e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (7.87e-4)" "unprognostic (7.23e-2)" "unprognostic (1.05e-3)" "unprognostic (1.02e-2)" 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.0 4.9 3075.8 0.1 0.1 0.1 0.1 0.1 38.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.0 0.0 0.3 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.1 315.9 0.0 8.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 7.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.5 0.0 2.6 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 683.8 0.0 0.0 0.0 0.1 12066.1 0.0 0.0 36.6 0.0 0.8 61.3 4.3 2.0 0.0 0.0 1612.0 237.4 2.3 0.2 0.1 0.0 49859.9 8.2 0.0 1.7 1417.3 1529.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 261.7 0.0 0.0 442.7 0.0 0.0 0.4 0.2 0.2 0.1 17.7 22.3 0.0 0.0 ASPH "BAH, CASQ2BP1, HAAH, JCTN" ENSG00000198363 "Aspartate beta-hydroxylase" Q12797 8 61500556-61714640 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Dioxygenase, Oxidoreductase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 462.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 102.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055161, HPA059303" Uncertain Enhanced "Endoplasmic reticulum" NA NA 900000 "Endoplasmic reticulum" "HPA055161: AB_2682721, HPA059303: AB_2683973" "unprognostic (8.07e-2)" "prognostic unfavorable (8.07e-5)" "unprognostic (1.73e-2)" "unprognostic (4.48e-2)" "unprognostic (2.32e-1)" "unprognostic (1.85e-2)" "unprognostic (2.82e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (6.39e-2)" "unprognostic (3.64e-1)" "prognostic unfavorable (1.75e-4)" "unprognostic (9.50e-2)" "prognostic unfavorable (1.57e-5)" "unprognostic (8.96e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (2.74e-2)" 104.6 60.4 27.3 15.0 29.5 4.8 84.3 35.2 31.3 22.3 23.8 10.6 18.3 14.0 16.8 17.8 22.4 16.5 19.1 33.9 26.1 22.4 19.0 23.0 22.5 10.9 21.1 22.2 20.5 13.8 12.5 15.7 14.7 20.5 17.3 26.8 23.6 28.8 23.4 103.1 12.0 13.9 26.1 16.7 12.8 30.5 6.4 19.6 2.9 31.7 36.0 13.7 30.0 25.4 3.3 21.0 15.9 5.2 4.9 3.4 2.3 49.9 72.6 10.2 6.2 45.7 43.5 3.5 89.7 83.3 38.4 40.3 12.4 66.6 3.8 6.2 52.5 30.9 18.7 6.3 31.3 65.7 1.4 6.4 8.9 44.1 33.9 29.3 1.3 1.4 35.7 7.0 21.3 27.3 75.4 16.2 2.0 2.4 3.6 33.8 10.6 0.3 1.8 5.8 48.4 42.8 2.4 11.0 0.8 23.4 41.4 10.6 3.6 27.8 13.1 11.1 5.8 5.3 2.4 50.8 38.9 20.0 35.5 31.6 2.3 2.9 0.1 102.4 0.8 26.0 1.1 5.2 0.1 1.6 1.9 3.1 3.3 2.3 1.6 6.1 3.3 3.4 1.6 15.9 4.9 1.0 21.0 2.3 2.3 27.3 29.5 35.2 31.3 26.1 22.4 21.1 22.2 20.5 19.6 181.7 183.4 8.3 108.3 41.8 126.7 192.2 22.9 57.6 137.6 82.0 276.9 97.4 13.3 97.2 1.6 71.6 39.8 0.0 158.3 85.9 64.5 113.1 8.1 51.6 62.4 120.8 111.8 38.6 25.4 0.5 65.6 43.4 40.5 13.6 178.8 462.0 186.9 24.6 54.1 31.9 150.0 45.3 73.9 2.6 16.8 44.0 40.2 10.0 58.7 212.3 ATL3 DKFZP564J0863 ENSG00000184743 "Atlastin GTPase 3" Q6DD88 11 63624087-63671921 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 242.0;Late spermatids: 574.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065702, HPA076616" Enhanced "Endoplasmic reticulum" NA NA 1600000 "Endoplasmic reticulum" "HPA065702: AB_2685536, HPA076616: AB_2732318" "unprognostic (4.19e-2)" "unprognostic (1.10e-1)" "unprognostic (8.32e-2)" "unprognostic (1.62e-1)" "unprognostic (6.89e-2)" "unprognostic (6.95e-2)" "unprognostic (1.91e-2)" "unprognostic (6.09e-3)" "unprognostic (3.38e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (4.52e-2)" "unprognostic (1.11e-3)" "unprognostic (7.41e-2)" "unprognostic (2.88e-1)" "unprognostic (1.04e-1)" "unprognostic (7.67e-3)" 40.3 17.7 7.9 11.8 10.4 8.2 28.3 5.6 7.4 20.9 15.0 12.4 14.0 6.7 22.5 15.7 23.4 14.5 15.1 9.7 7.0 5.0 15.0 23.6 15.9 24.7 10.9 5.4 22.3 18.4 12.9 8.8 11.8 9.8 17.9 11.7 14.0 17.5 15.4 7.6 20.3 11.0 35.6 12.8 12.0 14.1 43.3 10.7 11.0 18.9 14.2 13.0 32.2 22.3 6.2 9.6 6.6 13.7 7.4 11.8 8.1 13.3 12.9 3.6 8.9 19.3 26.3 0.0 15.9 18.9 16.0 11.0 10.3 21.0 7.8 16.5 27.4 12.3 8.6 6.8 10.7 23.1 11.6 1.8 7.9 14.5 0.0 12.7 15.6 12.0 16.7 18.0 20.5 13.4 10.7 17.2 9.1 8.8 21.9 18.5 14.5 5.7 9.8 4.6 4.4 10.2 12.3 9.1 11.7 13.3 9.6 2.0 5.5 47.6 11.4 15.3 5.0 21.0 6.0 23.7 33.7 16.1 32.9 11.1 6.2 8.5 15.8 18.1 10.5 20.4 6.6 9.1 4.0 10.8 12.4 11.8 6.2 9.0 8.7 9.6 5.2 7.5 10.1 3.9 7.4 13.7 4.8 9.9 8.1 7.9 10.4 5.6 7.4 7.0 5.0 10.9 5.4 9.8 10.7 41.7 22.7 18.0 39.1 38.8 4.3 7.8 30.6 13.4 21.6 31.4 0.0 5.8 1.7 37.0 242.0 45.4 28.8 23.3 43.5 16.5 29.6 47.3 16.2 46.1 35.2 4.8 10.3 47.9 54.0 574.9 50.3 34.8 40.5 40.5 18.4 12.4 59.3 22.9 63.3 18.2 7.0 71.1 60.4 25.8 27.3 35.5 3.3 23.5 15.9 44.8 BCAP31 "6C6-Ag, BAP31, CDM, DXS1357E" ENSG00000185825 "B cell receptor associated protein 31" P51572 X 153700492-153724746 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport" "Deafness, Dystonia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003906, CAB015350, CAB015424" Supported Approved Enhanced "Endoplasmic reticulum" NA NA 6800000 "Endoplasmic reticulum" "CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270" "unprognostic (1.02e-2)" "unprognostic (2.14e-2)" "unprognostic (1.19e-2)" "unprognostic (3.70e-1)" "unprognostic (2.36e-2)" "prognostic unfavorable (9.87e-4)" "unprognostic (3.25e-3)" "unprognostic (4.20e-2)" "unprognostic (1.27e-1)" "unprognostic (5.75e-2)" "unprognostic (1.38e-1)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (1.28e-2)" "unprognostic (8.61e-2)" "unprognostic (2.33e-1)" "unprognostic (1.02e-1)" 60.7 43.4 38.3 20.3 38.8 27.4 71.3 22.2 48.1 28.7 31.8 27.1 27.5 28.8 30.2 48.6 42.4 31.0 26.8 26.7 34.1 36.5 41.6 52.4 42.2 50.0 38.1 26.0 29.1 67.6 36.0 27.4 43.6 44.5 34.3 36.6 30.7 44.5 37.7 15.6 37.3 37.8 32.4 33.6 36.7 24.8 31.6 21.1 25.4 53.1 27.2 37.1 38.1 30.8 72.7 109.7 104.4 97.5 68.2 89.8 150.4 55.1 52.0 14.4 72.3 64.2 19.5 33.5 26.8 30.8 31.9 41.1 41.9 40.5 32.3 122.4 43.4 42.5 55.9 36.0 56.3 26.7 15.9 53.7 20.4 41.2 36.0 31.5 33.1 44.2 26.0 48.9 31.1 36.6 33.6 39.0 19.1 27.6 58.9 35.7 57.7 21.2 45.1 16.5 74.8 53.8 23.2 16.1 72.4 50.0 60.5 18.9 26.8 12.0 59.6 40.2 23.7 21.8 37.4 40.7 28.1 27.7 38.0 53.7 60.5 116.6 42.9 54.8 44.9 24.6 80.3 80.6 77.5 89.0 86.1 79.5 71.2 89.8 88.1 69.9 72.7 79.4 86.4 104.4 68.2 97.5 109.7 72.4 150.4 38.3 38.8 22.2 48.1 34.1 36.5 38.1 26.0 44.5 21.1 104.2 111.8 94.7 188.6 125.9 40.7 56.9 135.0 112.4 95.5 122.1 43.2 414.9 31.5 221.9 4.3 139.7 190.7 23.3 182.9 352.4 105.7 160.9 92.5 177.7 341.5 30.2 99.2 204.4 127.2 16.4 97.5 153.8 151.8 150.5 117.5 122.3 207.2 171.9 93.0 136.1 33.7 155.2 85.4 143.9 179.9 114.0 450.0 97.8 147.8 228.6 CANX "CNX, IP90, P90" ENSG00000127022 Calnexin P27824 5 179678628-179730925 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 109.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004738, HPA009433, HPA009696" Enhanced Enhanced "Endoplasmic reticulum" NA NA 82000000 "Endoplasmic reticulum" "CAB004738: AB_626784, HPA009433: AB_1078380, HPA009696: AB_1078379" "unprognostic (6.56e-2)" "unprognostic (9.34e-3)" "prognostic favorable (1.38e-4)" "unprognostic (1.19e-1)" "unprognostic (7.86e-2)" "unprognostic (1.41e-2)" "unprognostic (4.66e-3)" "unprognostic (8.57e-2)" "unprognostic (4.34e-2)" "unprognostic (1.25e-2)" "unprognostic (2.17e-3)" "unprognostic (4.48e-2)" "unprognostic (2.28e-1)" "unprognostic (1.87e-1)" "unprognostic (7.12e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (2.15e-1)" 49.3 35.4 40.0 35.8 40.9 57.6 37.8 27.3 49.1 93.0 33.6 37.1 48.3 44.0 42.7 115.4 31.6 31.7 30.0 51.3 36.9 50.9 61.6 120.8 34.7 30.1 47.5 27.9 41.0 78.2 13.7 33.0 70.5 44.9 33.5 55.1 32.2 121.5 48.5 28.5 23.4 68.5 60.5 48.8 38.2 31.7 34.3 30.0 31.0 113.4 25.9 29.9 41.4 47.6 10.1 26.3 25.9 28.9 18.7 22.6 30.0 8.4 23.8 20.2 12.3 43.5 32.3 10.2 43.5 47.8 50.3 42.7 20.7 19.5 63.9 61.1 34.8 25.6 5.8 31.7 23.7 57.5 16.4 9.6 10.3 59.3 13.4 59.3 19.6 9.7 6.3 43.6 27.0 78.5 15.4 20.8 4.9 8.1 24.9 5.5 7.8 9.9 0.3 4.1 3.6 1.4 10.3 14.7 7.0 37.0 24.9 10.2 2.4 12.2 5.2 109.0 25.3 41.2 8.7 38.6 11.5 19.2 13.0 33.7 7.6 26.2 16.1 17.4 12.8 11.2 25.9 28.9 8.8 17.7 21.2 22.6 10.1 13.9 16.3 26.3 7.7 9.5 10.6 6.1 18.7 18.0 25.3 10.1 30.0 40.0 40.9 27.3 33.3 36.9 50.9 47.5 27.9 44.9 30.0 184.6 236.5 93.5 89.0 131.9 112.0 432.6 180.9 323.9 284.4 172.7 149.2 138.7 41.4 148.7 197.6 180.1 166.6 46.7 132.3 187.5 146.3 221.3 188.7 393.6 206.3 151.0 170.9 163.9 186.1 659.2 147.3 192.4 167.0 120.8 179.5 201.8 157.0 97.9 179.6 160.8 108.3 90.5 152.7 141.2 80.8 141.4 204.7 88.6 178.9 131.5 CAST ENSG00000153113 Calpastatin P20810 5 96525267-96779595 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 201.9" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 948.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009491, HPA036881, HPA036882, HPA075906" Enhanced Enhanced "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA 18000000 "Endoplasmic reticulum, Cytosol" "Plasma membrane" "CAB009491: AB_2259755, HPA036881: AB_2675359, HPA036882: AB_2675360, HPA075906: " "unprognostic (2.17e-1)" "unprognostic (1.39e-1)" "unprognostic (2.44e-2)" "unprognostic (1.91e-2)" "unprognostic (4.68e-2)" "unprognostic (1.45e-1)" "unprognostic (3.79e-1)" "unprognostic (4.53e-3)" "unprognostic (1.94e-2)" "unprognostic (6.11e-3)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.66e-2)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.16e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (4.98e-4)" 38.3 20.7 10.4 25.0 16.3 22.1 32.0 8.7 21.7 38.0 44.6 10.5 18.6 25.6 24.8 25.9 87.4 19.5 25.5 98.5 11.9 10.6 27.2 38.2 29.5 21.1 14.3 12.5 26.9 14.8 22.3 25.3 52.6 24.8 30.0 34.5 12.7 38.7 23.2 201.9 40.7 56.3 36.2 18.7 21.7 22.2 21.2 15.6 10.1 25.6 51.2 34.1 42.2 57.0 24.5 32.7 12.4 48.0 18.3 26.6 27.2 48.5 40.0 6.8 17.7 41.1 76.6 24.0 34.6 49.0 27.7 36.1 9.9 29.6 7.0 32.7 46.9 41.3 82.6 12.9 47.1 33.5 45.1 12.2 9.0 42.4 11.7 31.6 5.9 15.7 34.6 43.6 39.7 64.9 38.7 30.9 5.4 7.5 22.7 33.7 15.3 2.9 0.2 5.3 13.2 14.9 2.7 23.0 12.0 55.0 20.5 28.7 6.9 35.3 19.4 22.6 16.2 11.8 6.4 41.1 37.8 16.1 25.2 34.9 7.6 20.2 3.3 42.9 3.2 10.4 2.5 48.0 7.0 26.6 29.0 25.2 24.5 23.9 26.5 32.7 22.7 12.2 16.3 12.4 18.3 32.2 9.0 24.2 27.2 10.4 16.3 8.7 21.7 11.9 10.6 14.3 12.5 24.8 15.6 375.2 182.6 82.4 358.6 212.9 34.7 740.0 140.1 410.9 277.5 102.9 17.7 150.3 112.7 215.3 948.1 166.8 282.7 280.4 218.0 79.9 187.6 259.7 169.0 148.0 103.8 12.7 136.3 108.6 206.2 312.7 159.3 211.5 124.9 235.4 207.6 36.8 240.8 170.9 137.6 98.2 16.9 90.5 162.6 20.9 10.1 220.1 117.7 139.5 143.0 490.4 CCDC47 GK001 ENSG00000108588 "Coiled-coil domain containing 47" Q96A33 17 63745250-63776351 "Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029674, HPA072573, HPA075958" Approved Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029674: AB_10602703, HPA072573: AB_2686535, HPA075958: " "unprognostic (6.33e-2)" "unprognostic (3.26e-2)" "prognostic favorable (2.17e-4)" "unprognostic (1.38e-1)" "unprognostic (3.54e-1)" "unprognostic (1.47e-2)" "unprognostic (1.53e-2)" "unprognostic (9.08e-2)" "unprognostic (1.57e-1)" "unprognostic (3.68e-1)" "unprognostic (2.73e-1)" "unprognostic (1.26e-1)" "unprognostic (8.35e-2)" "unprognostic (1.88e-1)" "unprognostic (6.43e-2)" "unprognostic (7.46e-2)" "unprognostic (1.16e-1)" 26.2 42.1 26.7 18.7 43.3 11.4 26.7 32.4 31.3 24.4 38.2 23.0 29.2 39.9 20.6 26.3 28.9 21.2 22.8 42.4 26.5 24.0 40.0 71.8 27.4 13.9 29.4 24.8 27.0 30.5 49.3 28.5 49.9 26.4 29.3 38.4 17.7 30.0 29.7 71.9 23.5 44.0 20.7 31.5 26.8 35.9 15.1 34.7 13.3 29.4 24.3 18.1 29.8 24.5 19.9 41.9 37.4 30.8 20.8 25.7 24.2 38.6 36.7 22.8 20.0 32.3 21.5 44.6 39.6 25.7 27.1 32.1 32.4 35.3 30.5 21.2 27.6 31.4 31.8 27.6 24.2 48.1 10.7 28.1 43.9 30.3 31.6 31.0 35.0 23.1 22.6 34.2 37.3 32.2 19.2 22.5 15.3 48.8 26.8 22.0 31.2 26.8 12.9 19.9 48.6 37.4 24.9 44.5 41.9 32.5 44.1 21.0 28.6 26.5 68.0 31.7 30.3 44.8 19.1 28.7 50.8 32.5 36.8 45.4 26.8 31.8 31.5 29.6 22.4 40.9 22.2 30.7 37.4 22.1 30.8 25.7 19.9 21.9 20.3 41.9 16.0 22.9 20.2 24.5 20.8 30.4 27.9 23.4 24.2 26.7 43.3 32.4 31.3 26.5 24.0 29.4 24.8 26.4 34.7 134.0 106.5 47.7 83.7 89.5 39.7 111.9 63.7 88.3 134.2 57.6 13.7 93.7 8.3 87.2 11.3 69.1 81.5 46.7 91.7 81.3 51.1 84.9 42.9 81.9 52.3 54.0 50.2 59.5 48.5 10.0 44.3 53.4 37.1 57.7 79.0 57.4 77.1 56.1 52.6 28.2 22.6 71.1 79.8 53.4 31.7 79.4 120.5 30.6 79.3 73.5 COMT ENSG00000093010 Catechol-O-methyltransferase P21964 22 19941607-19969975 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" "Methyltransferase, Transferase" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 139.3" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 779.9;Syncytiotrophoblasts: 542.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 118.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001169, CAB011233" Enhanced Enhanced "Endoplasmic reticulum,Vesicles" NA NA 560000 Vesicles "Endoplasmic reticulum" "CAB011233: , HPA001169: AB_1078402" "unprognostic (5.20e-2)" "unprognostic (2.73e-2)" "unprognostic (3.08e-2)" "prognostic favorable (3.68e-4)" "unprognostic (2.99e-2)" "unprognostic (2.32e-3)" "unprognostic (5.54e-3)" "unprognostic (9.14e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (2.14e-3)" "prognostic favorable (5.67e-4)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.27e-1)" "unprognostic (7.09e-2)" "unprognostic (3.97e-1)" "unprognostic (1.07e-2)" 18.6 49.0 29.4 14.3 28.8 24.3 27.8 19.6 32.9 22.4 23.4 42.4 36.1 21.0 19.8 33.8 58.1 19.4 36.8 28.1 28.9 22.3 31.1 139.3 30.9 17.0 29.0 18.4 36.3 27.2 14.1 12.7 59.0 23.3 25.7 8.9 24.9 67.3 30.9 21.5 27.7 28.6 15.5 41.0 17.8 24.8 18.2 23.7 11.5 19.2 44.0 32.0 36.3 28.0 11.2 55.1 10.9 60.0 12.9 15.6 28.0 19.1 19.7 2.3 19.5 22.2 19.8 0.8 21.8 27.4 18.7 21.4 16.7 22.4 7.7 9.7 31.1 7.4 26.3 3.7 23.3 5.0 16.7 24.9 13.8 10.5 39.0 41.5 23.0 5.5 25.2 28.9 16.2 16.1 18.0 17.5 12.5 55.7 16.5 15.0 118.8 9.0 41.3 4.8 52.7 6.7 13.6 19.5 10.6 19.7 60.8 9.5 8.4 7.2 61.7 18.0 1.3 13.3 64.7 20.9 33.4 12.8 10.9 16.3 6.1 2.6 6.3 36.0 31.0 23.0 10.2 60.0 10.9 15.6 39.9 12.8 11.2 10.8 12.6 47.7 10.7 9.6 10.6 2.4 12.9 26.6 55.1 13.3 28.0 29.4 28.8 19.6 32.9 28.9 22.3 29.0 18.4 23.3 23.7 116.1 64.8 45.5 189.7 90.7 68.3 29.9 109.5 88.3 85.3 144.8 9.8 779.9 271.9 173.4 3.6 68.7 98.5 0.0 167.1 75.3 99.4 123.4 70.4 231.9 281.1 23.8 81.1 74.9 149.0 7.4 124.3 142.1 227.7 154.1 89.3 151.7 163.3 110.1 169.0 60.7 34.5 135.8 91.5 4.4 5.3 107.9 542.4 36.6 110.1 180.5 CYP51A1 "CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1" ENSG00000001630 "Cytochrome P450 family 51 subfamily A member 1" Q16850 7 92112151-92142952 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Monooxygenase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.9" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 62.5;Alveolar cells type 2: 133.7;Club cells: 77.3;Early spermatids: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 96.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041325, HPA043508" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA041325: AB_2677411, HPA043508: AB_2678520" "unprognostic (6.68e-2)" "prognostic unfavorable (6.12e-4)" "unprognostic (3.48e-2)" "unprognostic (1.18e-2)" "unprognostic (7.82e-2)" "unprognostic (3.60e-2)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (9.84e-2)" "unprognostic (1.36e-1)" "unprognostic (9.75e-2)" "unprognostic (1.34e-1)" "unprognostic (1.59e-9)" "unprognostic (1.82e-1)" "unprognostic (2.73e-1)" "unprognostic (5.13e-2)" "unprognostic (1.09e-3)" 10.3 27.0 16.7 8.1 22.1 10.5 15.5 13.3 32.0 11.8 21.1 32.9 6.3 33.1 9.1 15.3 23.4 7.1 10.3 9.9 18.6 20.8 18.6 80.9 22.2 5.0 17.2 13.7 21.0 20.2 32.4 11.9 8.8 47.1 18.2 16.9 17.1 11.0 7.7 4.3 12.8 28.8 8.3 43.7 7.3 18.1 35.7 19.5 2.3 14.1 18.7 10.0 9.0 13.2 14.2 14.1 3.5 13.9 6.7 10.7 7.1 21.4 10.5 26.6 17.0 18.7 30.7 3.8 7.3 22.1 9.5 26.0 25.3 39.3 18.7 11.6 12.6 96.2 18.8 23.1 46.1 11.1 7.8 16.4 5.4 11.2 19.0 25.6 11.0 8.1 22.2 21.0 37.1 39.0 8.4 9.7 3.8 20.2 43.2 11.1 22.0 2.3 10.2 19.8 8.8 10.5 7.6 5.5 42.2 43.0 36.4 18.7 12.5 15.5 30.9 22.6 12.6 11.2 13.2 11.5 13.0 14.6 18.8 9.5 14.7 13.1 17.1 10.0 14.6 16.6 1.8 9.7 3.5 10.7 13.9 7.1 14.2 7.6 8.4 14.1 10.7 7.2 9.2 1.5 6.7 8.3 12.4 5.8 7.1 16.7 22.1 13.3 32.0 18.6 20.8 17.2 13.7 47.1 19.5 62.5 133.7 7.5 1.0 2.3 2.1 1.2 7.6 28.1 77.3 1.8 2.0 1.3 1.7 9.2 70.7 2.1 14.4 23.3 17.0 0.8 1.8 1.3 27.7 4.2 1.3 0.0 10.4 8.6 6.6 27.7 3.4 2.1 0.0 1.0 12.0 1.9 12.3 10.4 1.4 1.7 1.8 0.0 2.8 3.2 1.5 4.6 3.7 1.0 11.5 2.1 EDEM1 "EDEM, KIAA0212" ENSG00000134109 "ER degradation enhancing alpha-mannosidase like protein 1" Q92611 3 5187646-5219957 "Plasma proteins, Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 57.5;lymphoid tissue: 89.4" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 96.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 48.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029565 Uncertain Enhanced "Endoplasmic reticulum,Aggresome" NA NA "Endoplasmic reticulum" Aggresome "HPA029565: AB_10602032" "unprognostic (3.03e-1)" "unprognostic (3.02e-2)" "unprognostic (3.57e-3)" "unprognostic (4.30e-3)" "unprognostic (1.37e-1)" "unprognostic (2.60e-2)" "unprognostic (6.29e-2)" "unprognostic (2.09e-2)" "unprognostic (1.39e-1)" "unprognostic (6.49e-2)" "unprognostic (5.72e-3)" "unprognostic (1.51e-1)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "unprognostic (2.34e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" 6.5 7.6 5.3 13.1 6.7 26.3 7.0 4.8 6.3 6.7 7.6 4.5 5.1 5.9 8.4 6.4 10.5 7.0 6.2 4.8 4.3 3.1 6.6 57.5 14.2 16.9 3.9 5.0 8.6 20.3 10.2 6.5 14.2 4.2 6.6 7.6 5.5 9.7 5.7 3.7 10.1 11.8 5.4 3.7 15.4 7.8 7.8 4.0 89.4 7.8 5.5 23.5 8.8 8.1 9.9 10.3 4.3 5.8 2.9 8.9 2.8 4.7 4.8 3.0 3.0 4.0 9.0 9.7 7.8 10.6 5.4 7.1 2.2 6.3 25.5 4.2 7.7 11.8 3.7 3.3 10.7 8.3 48.9 1.9 8.7 4.5 4.9 18.8 10.2 25.5 8.1 13.1 11.5 12.7 7.3 10.7 33.3 2.2 35.3 6.6 2.8 20.5 3.9 1.5 2.2 3.6 29.9 5.4 23.4 6.2 10.0 0.4 4.0 5.6 8.1 11.5 2.8 4.1 32.9 10.4 10.4 7.3 8.8 8.9 20.8 12.6 43.9 17.3 9.9 8.6 3.5 3.8 4.0 5.8 5.0 8.4 9.9 8.8 6.5 4.6 6.8 7.9 6.2 4.3 2.9 5.8 10.3 8.9 2.8 5.3 6.7 4.8 6.3 4.3 3.1 3.9 5.0 4.2 4.0 56.6 96.8 35.0 6.3 18.3 4.1 2.8 17.8 6.7 20.5 15.7 9.8 8.0 0.0 6.0 9.1 11.3 14.8 0.0 10.5 26.0 8.7 10.9 23.1 65.7 15.8 1.6 8.1 14.7 33.3 37.6 7.8 35.8 15.1 47.7 22.7 3.5 14.0 0.0 8.5 7.0 3.5 0.0 12.2 6.7 2.0 23.8 34.2 21.4 10.1 16.1 ELOVL5 "dJ483K16.1, HELO1, SCA38" ENSG00000012660 "ELOVL fatty acid elongase 5" Q9NYP7 6 53267398-53349179 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 250.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017042, HPA047752, HPA054197" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413" "unprognostic (7.33e-2)" "unprognostic (5.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.92e-2)" "unprognostic (1.16e-1)" "unprognostic (5.01e-2)" "unprognostic (3.06e-1)" "unprognostic (2.19e-1)" "unprognostic (4.38e-2)" "unprognostic (1.43e-2)" "unprognostic (3.23e-1)" "unprognostic (6.40e-2)" "prognostic unfavorable (1.94e-6)" "unprognostic (1.58e-1)" "unprognostic (5.12e-2)" "prognostic unfavorable (6.80e-4)" "unprognostic (2.76e-2)" 75.7 48.7 17.9 24.2 22.0 33.9 78.8 13.3 22.1 18.2 13.9 38.3 91.2 9.7 15.7 18.0 10.8 16.5 18.0 14.6 18.3 17.5 13.5 36.8 24.4 33.6 41.1 12.3 13.1 5.7 8.1 11.6 13.6 26.4 45.2 6.7 16.1 9.4 88.4 3.6 11.4 17.3 18.0 46.4 18.5 9.5 34.8 29.1 28.7 17.6 5.6 33.6 16.6 19.4 23.8 18.1 60.7 11.3 8.4 25.3 10.4 25.3 18.5 32.5 59.3 86.2 50.1 13.8 29.6 33.3 23.9 33.6 16.4 29.4 28.8 21.5 30.7 37.6 15.0 32.0 27.1 35.9 24.2 22.5 28.4 17.3 22.8 47.4 22.4 20.8 46.2 21.3 23.9 30.1 24.2 26.5 57.5 35.4 16.8 17.2 2.7 66.5 19.9 17.5 0.9 14.2 26.0 22.3 10.0 45.0 15.2 30.3 20.8 24.5 12.8 24.8 22.1 29.2 21.0 25.1 26.3 23.4 46.8 38.9 14.1 13.0 21.9 13.7 32.6 18.6 9.0 11.3 40.7 8.8 8.1 14.2 21.6 14.7 10.6 18.1 23.8 7.2 6.7 60.7 8.4 9.6 4.8 25.3 10.4 17.9 22.0 13.3 20.2 18.3 17.5 41.1 12.3 26.4 29.1 74.5 46.1 107.2 78.7 46.5 7.7 20.2 22.9 49.5 31.8 12.2 2.0 21.5 13.3 32.0 79.1 51.7 5.1 0.0 31.8 46.1 52.2 250.9 98.0 83.9 32.1 7.9 24.0 41.1 61.4 135.1 19.2 53.0 45.5 16.2 0.6 75.7 19.7 0.6 30.1 34.2 5.2 64.7 88.4 20.7 10.4 53.2 26.1 87.3 4.3 62.0 EMD "LEMD5, STA" ENSG00000102119 Emerin P50402 X 154379197-154381523 "Disease related genes, Predicted membrane proteins" Actin-binding "Cardiomyopathy, Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000609, CAB001545, CAB002029, CAB058694, CAB062552" Supported Enhanced "Nuclear membrane,Endoplasmic reticulum" NA NA 520000 "Nuclear membrane" "Endoplasmic reticulum" "CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: AB_2665587, CAB062552: AB_2665586, HPA000609: AB_1078736" "unprognostic (2.92e-1)" "unprognostic (6.59e-3)" "unprognostic (4.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.16e-1)" "unprognostic (9.12e-3)" "unprognostic (3.58e-2)" "unprognostic (6.06e-3)" "unprognostic (7.74e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-2)" "unprognostic (1.49e-1)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (7.74e-2)" "unprognostic (2.02e-2)" "unprognostic (1.99e-1)" 25.0 17.5 14.0 17.6 16.0 21.0 26.5 15.8 21.8 24.8 21.3 13.7 22.3 14.0 32.3 25.7 22.9 27.2 28.7 29.5 13.1 14.1 18.2 21.2 22.0 37.4 13.3 16.5 35.9 29.4 20.5 22.8 15.4 11.9 25.5 11.4 20.7 24.5 29.1 62.0 18.1 13.7 40.4 13.1 17.6 20.1 16.1 9.7 16.6 28.1 24.4 18.3 31.7 20.6 23.2 30.5 24.5 19.7 14.7 26.9 15.8 30.6 11.6 8.0 8.8 7.3 14.6 14.4 15.1 16.2 19.3 20.3 10.3 6.0 24.4 23.0 15.5 40.7 17.1 15.3 18.7 8.2 14.3 33.4 11.4 17.0 6.0 19.8 11.0 12.6 12.8 14.9 17.2 21.5 13.0 13.4 10.4 9.4 10.5 13.1 13.0 19.2 20.2 13.4 17.9 36.2 16.0 12.0 23.3 10.4 5.9 10.2 12.6 7.8 13.1 18.4 8.1 9.2 8.3 12.1 9.6 18.3 21.6 21.6 34.4 25.5 44.0 11.7 18.6 10.4 16.6 16.9 24.5 26.9 19.7 25.0 22.5 25.7 25.7 13.5 23.2 23.1 22.4 18.1 14.7 14.0 30.5 23.9 15.8 14.0 16.0 15.8 21.8 13.1 14.1 13.3 16.5 11.9 9.7 29.8 39.9 28.9 65.6 63.7 31.2 18.5 30.6 20.1 30.7 26.2 11.8 50.6 59.7 39.0 13.8 27.2 18.0 0.0 47.4 56.3 49.5 56.7 53.2 33.5 46.5 28.6 23.0 27.0 17.1 11.2 37.7 46.4 64.1 59.5 33.9 40.7 39.0 28.8 42.1 35.0 29.9 25.8 51.0 10.7 34.1 67.2 104.6 47.8 27.5 59.3 FAU "asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30" ENSG00000149806 "FAU, ubiquitin like and ribosomal protein S30 fusion" "P35544, P62861" 11 65120628-65122473 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059015 Supported Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" No No "Endoplasmic reticulum, Cytosol" Nucleoli "HPA059015: AB_2683881" "unprognostic (1.81e-3)" "unprognostic (3.47e-2)" "unprognostic (2.89e-1)" "unprognostic (2.91e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-3)" "unprognostic (1.97e-1)" "unprognostic (5.40e-2)" "unprognostic (1.26e-1)" "unprognostic (7.06e-3)" "unprognostic (7.77e-2)" "unprognostic (1.14e-1)" "unprognostic (1.61e-2)" "unprognostic (1.13e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-3)" "unprognostic (1.45e-2)" 79.7 95.0 90.6 84.9 76.2 186.7 95.4 50.9 80.9 103.6 134.8 77.6 63.4 77.8 84.0 80.5 115.2 100.0 87.2 133.9 70.0 58.9 88.0 162.9 77.5 182.6 78.9 40.8 176.0 202.8 27.5 56.1 73.2 46.6 123.5 53.0 67.8 97.3 76.7 190.8 86.8 93.8 97.5 72.4 130.9 79.2 53.6 53.2 126.8 121.5 83.6 149.5 122.0 136.6 291.3 169.7 90.9 119.0 116.3 253.8 346.5 78.9 52.0 46.0 72.8 45.0 67.3 63.0 45.1 43.9 63.2 40.1 58.8 79.3 94.1 122.5 38.7 42.6 69.8 42.6 60.1 26.3 69.0 65.3 75.8 54.7 80.7 82.8 89.8 83.6 82.9 100.1 54.3 73.9 60.2 48.7 91.0 70.7 111.5 33.4 98.7 103.8 181.4 126.5 59.2 86.7 101.0 36.8 184.5 58.2 44.7 64.0 64.3 35.0 101.3 140.8 28.6 90.5 124.6 46.0 57.2 66.0 88.2 72.0 121.3 115.2 160.1 69.3 70.0 64.7 90.9 119.0 70.6 128.9 107.0 176.1 291.3 212.1 165.5 132.1 281.7 253.8 198.1 78.9 116.3 92.8 169.7 153.8 346.5 90.6 76.2 50.9 80.9 70.0 58.9 78.9 40.8 46.6 53.2 595.5 951.7 2941.4 2547.1 3351.7 327.7 460.8 1579.6 745.5 1039.6 909.0 184.6 1889.5 1737.5 1225.7 710.1 1573.3 1664.2 1027.9 2337.8 2188.3 1714.1 2189.0 1307.1 1658.9 1928.3 179.6 1179.1 1412.4 2371.4 1489.6 2116.5 2866.9 2014.3 2418.4 1788.3 428.5 1806.3 2457.4 1155.5 1844.9 362.4 1099.5 2206.1 745.0 649.0 3667.7 2335.8 2033.7 2040.2 2956.6 FGB ENSG00000171564 "Fibrinogen beta chain" P02675 4 154562956-154571086 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 189 "liver: 1908.6" "Cell type enriched" "Detected in some" 33 "Hepatocytes: 15347.2" "Cancer enriched" "Detected in many" 42 "liver cancer: 2262.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "Hep G2: 77.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001900, HPA001901, CAB008624" Enhanced Enhanced "Endoplasmic reticulum" "Secreted to blood" NA NA 120000000000 "Endoplasmic reticulum" "CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864" "unprognostic (1.16e-1)" "unprognostic (3.89e-2)" "unprognostic (4.65e-2)" "unprognostic (3.44e-1)" "unprognostic (2.20e-3)" "unprognostic (1.42e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (5.72e-5)" "unprognostic (2.48e-2)" "unprognostic (7.91e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.1 1908.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 77.7 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 153.8 0.0 0.0 0.0 0.4 257.4 0.0 0.0 3.5 0.0 0.0 1.7 3.0 0.4 0.0 0.0 467.2 3.2 0.1 0.0 0.0 0.0 15347.2 0.3 0.0 1.7 349.9 342.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.0 HACD3 "B-ind1, HSPC121, PTPLAD1" ENSG00000074696 "3-hydroxyacyl-CoA dehydratase 3" Q9P035 15 65530418-65578352 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014837, HPA060347" Enhanced Enhanced "Endoplasmic reticulum" NA NA 27000 "Endoplasmic reticulum" "HPA014837: AB_1855914, HPA060347: AB_2684260" "unprognostic (1.51e-2)" "unprognostic (2.89e-1)" "unprognostic (2.29e-1)" "unprognostic (2.18e-1)" "unprognostic (3.52e-1)" "unprognostic (1.92e-2)" "unprognostic (1.67e-1)" "unprognostic (2.28e-1)" "unprognostic (3.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.57e-1)" "prognostic favorable (3.09e-5)" "unprognostic (3.44e-2)" "unprognostic (5.33e-2)" "unprognostic (1.10e-2)" "unprognostic (2.04e-2)" 9.6 37.4 31.0 7.4 36.0 6.2 33.3 28.6 37.6 18.5 12.5 24.2 10.1 12.2 13.1 19.4 8.4 14.3 14.7 5.9 29.2 44.8 35.0 50.0 12.7 7.2 36.5 26.0 21.7 12.6 22.5 33.9 15.9 45.9 18.5 15.1 17.9 11.6 15.8 3.3 11.7 12.0 12.2 41.5 8.5 29.0 13.9 19.7 8.9 30.7 5.6 8.3 18.8 10.4 13.0 9.0 2.7 6.1 11.7 19.9 11.2 19.4 43.6 48.5 24.2 30.6 18.5 23.0 21.6 18.7 24.6 27.8 33.4 29.2 24.5 18.9 23.4 30.7 53.9 78.2 18.0 22.1 13.6 43.6 19.5 21.9 36.4 15.5 24.1 15.0 18.9 13.5 16.8 12.2 23.8 23.9 14.7 25.5 9.3 39.6 23.2 17.8 18.8 41.3 52.2 14.8 20.2 41.1 27.6 35.1 33.9 29.3 25.9 23.3 26.3 24.4 47.7 26.7 12.8 18.9 31.3 27.6 15.3 29.9 18.2 54.0 34.6 20.9 23.6 18.7 2.7 3.9 1.2 17.6 5.8 19.9 13.0 16.1 16.6 6.8 13.0 18.9 18.5 0.4 11.7 6.1 9.0 12.4 11.2 31.0 36.0 28.6 34.1 29.2 44.8 36.5 26.0 45.9 19.7 59.6 49.7 22.9 50.2 0.0 116.3 6.4 61.1 66.9 51.2 167.5 94.2 155.3 21.6 61.1 83.6 35.9 7.7 46.7 39.9 101.8 47.3 63.7 15.1 153.2 44.7 131.9 42.1 42.4 18.0 21.8 80.8 16.2 0.0 3.6 25.8 78.8 35.8 14.0 83.1 44.0 65.7 77.6 27.2 123.2 116.2 0.0 94.6 13.1 52.6 77.6 HSP90B1 "GP96, GRP94, TRA1" ENSG00000166598 "Heat shock protein 90 beta family member 1" P14625 12 103930107-103953645 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 325.1;thyroid gland: 338.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003901, CAB005224, HPA008424, CAB078151" Enhanced Enhanced "Endoplasmic reticulum" "Intracellular and membrane" NA NA 410000000 "Endoplasmic reticulum" "CAB005224: AB_2119181, CAB078151: AB_2665765, HPA003901: AB_1851181, HPA008424: AB_1851184" "unprognostic (1.03e-1)" "unprognostic (3.44e-2)" "unprognostic (1.18e-1)" "unprognostic (5.70e-2)" "unprognostic (1.17e-2)" "unprognostic (7.14e-3)" "unprognostic (3.00e-2)" "unprognostic (7.22e-2)" "unprognostic (8.77e-2)" "unprognostic (8.30e-2)" "unprognostic (2.76e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.03e-10)" "unprognostic (2.95e-1)" "unprognostic (2.39e-1)" "unprognostic (1.24e-1)" "unprognostic (1.28e-2)" 49.0 57.1 26.9 50.0 32.0 45.9 60.3 16.5 25.5 45.7 43.4 17.5 108.5 32.1 42.2 127.2 34.3 42.0 32.4 67.0 27.1 32.0 74.0 325.1 46.6 49.2 31.5 26.0 53.9 95.5 47.1 50.0 123.6 29.4 46.9 46.9 15.8 43.8 136.8 25.4 19.2 54.4 45.0 37.8 89.3 37.0 25.7 27.9 44.5 338.5 24.0 36.9 66.1 106.1 25.6 81.0 22.2 23.8 40.2 53.3 33.9 72.0 39.1 78.9 81.0 80.8 76.3 107.1 121.5 91.9 64.7 86.4 69.7 67.6 21.1 96.6 127.5 83.5 50.4 77.7 130.5 87.4 49.8 29.6 56.7 44.1 71.9 124.7 57.1 44.4 44.7 58.2 79.7 114.4 219.3 124.5 25.7 45.3 80.2 85.5 25.9 34.3 63.9 64.9 73.3 47.1 31.3 50.9 88.1 86.6 45.5 23.4 56.2 75.8 78.5 76.6 126.8 63.8 84.9 71.6 49.0 42.0 39.8 50.6 82.1 76.8 39.0 97.7 42.3 75.8 22.2 21.2 6.9 45.6 23.8 53.3 25.6 26.7 39.3 28.0 15.9 18.0 31.3 4.9 40.2 19.3 81.0 16.4 33.9 26.9 32.0 16.5 25.5 27.1 32.0 31.5 26.0 29.4 27.9 220.3 319.5 129.9 714.2 274.9 44.0 581.2 221.7 394.9 445.9 244.3 147.3 520.4 48.0 366.6 40.3 299.0 344.0 186.9 218.9 824.3 597.0 564.5 392.9 721.4 494.0 73.1 389.8 556.8 268.7 19.1 521.5 350.1 399.9 234.4 276.1 146.4 329.7 262.6 317.5 229.3 75.2 213.4 401.9 313.5 187.6 227.8 770.3 202.8 314.4 519.2 IKBIP "FLJ31051, IKIP" ENSG00000166130 "IKBKB interacting protein" Q70UQ0 12 98613405-98645113 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 19.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 19.8" "Cell line enhanced" "Detected in all" "BJ: 53.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038677, HPA038678, HPA061541" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA038677: AB_2676146, HPA038678: AB_10672723, HPA061541: AB_2684555" "unprognostic (3.06e-1)" "unprognostic (1.06e-3)" "unprognostic (2.13e-1)" "unprognostic (4.34e-2)" "unprognostic (1.94e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (4.00e-5)" "unprognostic (6.28e-3)" "unprognostic (1.78e-1)" "unprognostic (3.83e-1)" "unprognostic (7.37e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (4.60e-9)" "unprognostic (7.37e-2)" "unprognostic (1.66e-1)" "unprognostic (3.46e-1)" "unprognostic (3.16e-2)" 21.0 8.9 3.7 12.2 4.6 3.6 13.6 1.1 4.0 17.0 12.3 1.7 6.0 3.3 9.5 10.2 8.5 7.3 11.0 23.6 4.0 3.7 17.0 25.3 16.1 14.0 4.2 1.7 12.8 5.8 4.1 12.6 22.1 6.3 12.2 6.1 3.6 7.6 6.7 10.0 3.2 6.2 13.3 5.2 30.6 5.3 5.8 3.8 15.2 19.8 6.2 7.8 15.1 26.2 3.3 3.7 19.8 4.3 3.7 2.4 1.1 3.2 10.1 11.6 7.2 27.9 29.5 10.1 53.6 32.9 14.2 18.1 2.2 3.2 10.8 9.2 32.9 9.9 7.0 4.5 20.5 24.1 3.2 6.9 4.1 6.5 15.2 10.7 7.6 8.2 22.1 4.4 16.3 14.7 26.0 19.9 2.0 6.2 4.3 34.9 3.0 3.4 17.6 4.4 2.6 8.8 3.0 16.7 5.4 23.4 3.7 1.7 5.6 15.3 1.1 8.5 20.3 3.3 9.5 18.6 30.3 10.8 13.3 13.7 4.6 4.9 8.1 9.0 7.0 21.8 6.0 4.3 12.6 2.1 3.3 2.4 3.3 1.3 2.1 3.7 2.2 1.4 1.5 19.8 3.7 3.7 2.6 1.6 1.1 3.7 4.6 1.1 4.0 4.0 3.7 4.2 1.7 6.3 3.8 11.9 17.8 22.0 12.9 6.8 3.2 2.6 0.0 5.3 21.6 3.5 3.9 28.7 10.0 9.6 1.6 38.4 1.1 0.0 5.0 49.4 34.3 6.4 19.7 8.9 40.4 3.2 0.0 32.5 25.0 2.5 28.4 36.1 13.5 21.6 3.8 2.3 5.8 2.9 15.9 8.5 2.5 38.8 19.1 30.8 14.0 6.4 8.5 20.8 1.7 4.6 KTN1 "CG1, KIAA0004, KNT" ENSG00000126777 "Kinectin 1" Q86UP2 14 55559072-55701526 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003178, CAB015331, HPA017876" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB015331: , HPA003178: AB_1079218, HPA017876: AB_1852652" "unprognostic (7.00e-3)" "unprognostic (2.99e-2)" "unprognostic (8.60e-2)" "unprognostic (5.50e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (6.83e-5)" "prognostic unfavorable (3.76e-4)" "unprognostic (1.75e-1)" "unprognostic (1.21e-2)" "unprognostic (1.01e-1)" "unprognostic (9.08e-2)" "unprognostic (8.72e-2)" "prognostic favorable (1.01e-6)" "unprognostic (1.27e-1)" "unprognostic (2.75e-1)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" 26.5 27.5 30.8 18.9 37.3 9.5 44.2 30.8 35.2 22.7 28.8 15.8 23.4 13.0 18.8 30.8 26.1 16.8 18.1 36.1 32.2 25.3 33.1 31.8 21.2 16.9 39.3 24.5 23.1 22.8 48.3 54.7 21.3 49.5 26.9 28.7 13.1 21.4 24.0 101.9 41.4 20.1 40.5 51.9 22.1 18.9 40.9 42.0 14.5 33.3 37.9 17.9 32.7 39.7 35.6 58.3 27.0 15.5 19.6 24.0 4.8 40.7 28.2 21.1 23.0 29.2 28.0 30.6 33.3 26.8 20.9 18.6 18.8 50.7 31.4 47.7 34.2 22.3 76.3 25.8 29.0 35.4 52.8 14.1 22.2 46.7 35.6 27.6 32.5 18.0 26.0 26.6 25.8 44.8 45.0 34.3 25.1 21.6 18.4 40.1 31.8 27.9 19.3 16.2 18.9 42.1 22.3 55.5 14.9 52.5 64.1 26.0 21.7 52.7 24.2 29.2 45.0 25.1 20.9 48.3 42.8 54.8 21.9 31.2 8.3 11.2 23.4 50.1 19.1 23.7 27.0 14.8 14.6 19.6 13.1 18.7 28.3 23.2 22.1 14.2 35.6 24.0 20.6 9.4 19.6 15.5 58.3 14.8 4.8 30.8 37.3 30.8 35.2 32.2 25.3 39.3 24.5 49.5 42.0 285.9 218.9 134.1 191.3 581.3 188.0 751.3 254.8 254.3 215.0 406.5 339.7 116.7 26.6 214.2 480.1 300.8 208.9 46.7 262.9 169.7 168.2 247.6 130.6 360.3 102.3 308.3 215.0 264.6 155.1 281.2 230.1 161.1 163.6 161.5 208.3 454.2 307.7 252.8 415.1 100.9 370.8 329.8 235.9 615.9 350.9 632.0 137.8 123.1 224.4 298.6 LRRC59 "FLJ21675, PRO1855" ENSG00000108829 "Leucine rich repeat containing 59" Q96AG4 17 50375059-50397553 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030827, HPA030829" Enhanced Enhanced "Endoplasmic reticulum" NA NA 5400000 "Endoplasmic reticulum" "HPA030827: AB_10602704, HPA030829: AB_10670045" "unprognostic (4.73e-2)" "unprognostic (2.15e-2)" "prognostic favorable (2.60e-4)" "unprognostic (5.63e-3)" "unprognostic (2.80e-1)" "prognostic unfavorable (1.00e-5)" "prognostic unfavorable (3.12e-6)" "unprognostic (1.88e-3)" "unprognostic (9.95e-2)" "unprognostic (5.62e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (3.68e-2)" "prognostic unfavorable (1.19e-6)" "unprognostic (2.77e-1)" "unprognostic (1.44e-1)" "unprognostic (3.39e-3)" "prognostic unfavorable (1.90e-5)" 20.7 40.5 10.6 21.8 14.5 28.4 16.3 11.5 21.6 28.2 30.0 11.4 28.8 19.6 17.2 24.9 23.5 15.8 22.8 17.4 10.2 8.8 22.1 74.7 23.0 15.9 12.7 11.5 15.8 87.9 15.4 11.6 35.3 10.8 17.7 31.5 10.0 48.6 26.2 16.0 11.2 27.3 22.0 8.9 19.0 30.7 18.2 10.4 18.0 22.8 22.4 20.8 13.7 17.0 8.6 14.9 14.4 19.6 5.9 9.1 9.0 62.1 47.4 13.6 20.5 23.2 27.4 24.5 51.0 28.5 47.8 42.3 108.3 18.0 27.2 35.0 58.0 29.4 22.7 33.9 43.5 57.1 14.4 49.4 47.6 26.9 57.9 48.7 46.7 22.6 24.1 35.4 51.1 59.6 13.9 35.2 15.8 44.0 25.9 31.3 42.3 32.9 22.2 15.4 58.8 69.5 28.2 43.9 52.0 26.0 31.7 33.5 27.8 17.6 19.8 25.9 21.2 33.4 25.4 37.5 55.5 23.0 51.1 66.3 39.0 31.9 35.2 37.6 31.8 34.8 14.4 15.7 13.4 7.4 19.6 9.1 8.6 7.5 8.9 14.9 6.4 5.0 6.3 8.0 5.9 18.6 12.1 7.5 9.0 10.6 14.5 11.5 21.6 10.2 8.8 12.7 11.5 10.8 10.4 20.8 21.3 38.0 75.9 123.9 20.8 4.0 38.2 14.7 35.2 19.2 2.0 78.1 24.9 166.2 37.0 22.6 79.6 23.3 164.5 210.3 84.3 117.1 30.0 58.2 94.9 20.6 36.8 25.8 26.9 12.2 32.8 46.2 62.4 46.9 93.0 24.6 158.0 71.6 27.3 38.3 11.1 12.9 67.0 41.7 28.5 115.9 197.4 27.7 82.6 133.9 MTDH "3D3, AEG-1, LYRIC" ENSG00000147649 Metadherin Q86UE4 8 97644179-97728770 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010932, HPA015104, CAB068204, CAB068205" Supported Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB068204: AB_2665655, CAB068205: AB_2665654, HPA010932: AB_1079422, HPA015104: AB_1854173" "unprognostic (1.01e-3)" "unprognostic (1.41e-2)" "unprognostic (2.05e-2)" "unprognostic (6.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.24e-2)" "unprognostic (4.08e-2)" "prognostic unfavorable (7.76e-4)" "unprognostic (1.25e-1)" "unprognostic (2.08e-1)" "prognostic unfavorable (5.36e-4)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.82e-4)" "unprognostic (3.84e-3)" "unprognostic (3.88e-2)" "unprognostic (2.77e-1)" "unprognostic (1.40e-1)" 26.5 28.5 17.2 28.3 21.9 44.5 29.0 21.8 20.2 27.5 24.9 20.7 24.7 23.2 31.6 28.6 27.6 23.6 23.5 23.6 18.7 16.6 24.3 97.8 21.9 31.4 26.5 19.6 26.7 22.7 27.1 18.0 13.4 23.0 24.0 22.8 16.4 22.3 21.2 49.8 19.5 32.7 29.5 34.6 35.8 21.8 19.0 24.8 40.0 30.5 22.7 27.5 27.5 35.7 26.2 42.4 17.4 26.6 19.2 20.9 10.1 38.8 20.2 13.2 18.1 22.0 23.3 6.5 35.0 29.8 22.4 17.4 11.9 29.1 36.0 39.5 34.3 24.8 25.9 32.0 24.3 31.4 38.3 16.8 66.1 21.9 14.1 26.7 34.6 30.8 17.8 24.5 27.1 61.8 21.2 25.7 26.6 43.1 64.0 23.7 16.1 58.3 9.6 8.1 34.0 24.6 38.2 15.7 52.3 14.6 22.4 20.0 15.0 24.8 21.9 27.4 13.3 33.4 22.2 26.7 31.8 11.4 29.2 25.8 35.7 38.9 36.5 29.2 40.7 27.7 17.4 26.6 13.4 14.2 17.8 20.1 26.2 20.4 20.9 32.6 18.6 20.8 18.4 3.8 19.2 19.5 42.4 11.7 10.1 17.2 21.9 21.8 20.2 18.7 16.6 26.5 19.6 23.0 24.8 119.1 103.5 196.6 171.8 232.4 0.0 87.6 201.2 52.2 100.1 134.3 0.0 9.1 21.6 197.1 211.2 149.0 122.0 46.7 201.2 89.0 152.1 236.8 136.0 389.3 243.9 0.0 116.8 148.0 225.6 132.2 180.9 250.7 175.5 149.7 148.0 0.0 214.1 126.3 203.3 76.1 0.0 219.9 203.9 116.5 108.0 275.1 11.4 146.0 177.0 291.2 MXRA7 "FLJ46603, PS1TP1, TMAP1" ENSG00000182534 "Matrix remodeling associated 7" P84157 17 76672551-76711016 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 140.1;Muller glia cells: 291.2;Peritubular cells: 134.7;Rod photoreceptor cells: 125.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 93.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044819, HPA075316" Uncertain Enhanced "Endoplasmic reticulum" "Secreted - unknown location" NA NA "Endoplasmic reticulum" "HPA044819: AB_10964134, HPA075316: " "unprognostic (1.34e-1)" "unprognostic (2.00e-1)" "unprognostic (1.32e-1)" "unprognostic (2.92e-1)" "unprognostic (1.19e-1)" "unprognostic (3.16e-2)" "prognostic unfavorable (4.70e-4)" "unprognostic (3.38e-2)" "unprognostic (1.21e-1)" "unprognostic (1.51e-3)" "unprognostic (2.07e-2)" "unprognostic (8.33e-2)" "unprognostic (5.39e-3)" "unprognostic (4.67e-3)" "unprognostic (6.21e-2)" "unprognostic (4.63e-3)" "prognostic unfavorable (1.80e-5)" 28.4 46.7 14.7 18.2 43.2 1.8 32.4 15.6 30.5 31.0 44.0 14.6 16.9 6.6 44.5 40.4 33.2 28.0 28.1 93.3 15.1 13.1 14.1 5.1 24.7 13.3 16.2 16.3 36.1 16.4 40.1 7.8 21.1 20.6 32.8 14.5 41.9 15.0 61.7 13.9 10.8 13.3 59.9 15.8 31.4 21.9 20.7 10.0 6.4 51.0 9.3 6.6 44.7 31.4 2.9 3.6 1.9 3.9 7.8 7.0 4.0 2.5 7.6 11.4 21.5 60.5 55.4 5.7 36.1 29.3 26.4 25.8 10.2 0.4 0.0 16.4 49.9 27.6 10.3 12.7 20.0 43.2 0.1 12.6 6.5 5.7 16.9 37.0 3.0 0.8 34.4 23.9 30.6 25.2 59.4 38.8 1.6 4.6 0.1 60.8 0.7 0.3 2.1 3.6 4.0 21.6 5.7 44.9 2.1 21.2 0.6 4.0 29.1 10.7 0.1 20.6 34.0 7.1 3.9 47.5 59.7 12.7 24.3 37.9 3.4 0.6 0.1 93.7 1.3 8.6 1.5 3.9 0.8 6.3 1.2 4.8 2.9 3.5 7.0 3.1 0.7 2.3 4.9 1.9 7.8 0.4 3.6 0.8 4.0 14.7 43.2 15.6 30.5 15.1 13.1 16.2 16.3 20.6 10.0 14.9 10.5 2.9 23.3 9.2 140.1 103.5 2.5 9.4 11.4 29.6 90.3 1.0 1.7 20.9 3.3 36.2 0.9 0.0 3.6 4.2 41.8 16.2 2.3 3.2 2.8 104.9 6.4 54.0 5.6 6.6 93.7 2.2 13.5 1.8 5.6 291.2 7.9 0.0 134.7 5.8 125.1 12.9 36.0 1.2 12.1 7.8 0.7 9.6 1.2 18.1 NSDHL "H105e3, SDR31E1, XAP104" ENSG00000147383 "NAD(P) dependent steroid dehydrogenase-like" Q15738 X 152830967-152869729 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation, Ichthyosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000248, HPA000571" Enhanced Enhanced "Endoplasmic reticulum,Lipid droplets" NA NA "Endoplasmic reticulum" "Lipid droplets" "HPA000248: AB_1079507, HPA000571: AB_1079506" "unprognostic (1.84e-1)" "prognostic favorable (5.65e-4)" "unprognostic (2.66e-1)" "unprognostic (1.81e-1)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.04e-4)" "unprognostic (1.03e-1)" "unprognostic (5.70e-2)" "unprognostic (4.32e-2)" "unprognostic (5.62e-2)" "unprognostic (2.63e-1)" "prognostic favorable (6.09e-5)" "unprognostic (3.53e-2)" "unprognostic (1.36e-1)" "unprognostic (3.91e-2)" "unprognostic (4.79e-2)" 17.4 24.8 11.0 7.7 10.5 6.0 20.4 7.7 15.0 13.4 23.4 13.9 20.5 13.3 10.4 35.7 36.2 11.9 7.4 16.7 14.3 11.4 11.6 38.1 9.9 8.7 9.7 10.4 9.8 7.9 9.8 6.9 7.9 18.9 12.0 10.7 7.9 12.2 17.7 6.9 14.5 24.0 9.9 14.2 7.3 9.6 8.6 9.3 6.0 11.0 22.2 17.0 7.5 16.1 16.2 17.5 16.4 17.7 17.0 17.3 13.0 40.6 14.9 20.4 10.6 17.6 13.4 11.5 8.1 10.9 14.8 18.8 20.6 22.2 20.1 27.3 11.0 55.0 20.9 26.5 37.5 13.1 6.7 15.2 8.2 14.6 20.9 12.8 8.2 6.7 16.4 14.5 28.9 7.3 6.4 13.7 8.9 13.6 9.1 11.2 18.0 8.0 10.7 8.1 20.4 18.0 6.0 14.8 16.5 30.7 16.8 7.4 8.4 7.2 10.9 8.5 14.8 7.2 10.5 11.6 6.9 11.4 16.6 15.6 12.9 8.6 34.6 12.8 12.9 6.5 16.4 17.7 15.8 15.6 16.2 15.7 16.2 15.6 13.5 17.5 12.9 11.4 12.6 1.9 17.0 12.1 15.6 17.3 13.0 11.0 10.5 7.7 15.0 14.3 11.4 9.7 10.4 18.9 9.3 11.9 14.7 9.7 9.8 9.6 3.8 21.0 15.3 18.7 10.3 12.2 0.0 18.3 8.3 16.9 8.7 7.4 12.0 0.0 17.6 18.3 9.8 7.8 8.1 26.3 16.1 1.6 5.8 8.0 8.3 5.9 7.8 9.3 5.0 15.4 8.7 10.3 16.2 7.8 8.5 11.5 5.4 0.0 8.2 3.7 8.2 10.7 15.6 5.7 9.4 15.3 P4HA2 C-P4Halpha(II) ENSG00000072682 "Prolyl 4-hydroxylase subunit alpha 2" O15460 5 132191838-132295315 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 62.2;U-87 MG: 60.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA016997, HPA027824, CAB062557" Enhanced Enhanced "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" No No "Endoplasmic reticulum, Vesicles" "CAB062557: AB_2665641, HPA016997: AB_2669501, HPA027824: AB_2672402" "unprognostic (1.30e-3)" "prognostic unfavorable (1.24e-5)" "unprognostic (2.56e-3)" "unprognostic (1.28e-3)" "unprognostic (2.08e-3)" "unprognostic (1.62e-3)" "unprognostic (1.16e-3)" "unprognostic (1.93e-3)" "unprognostic (2.83e-2)" "unprognostic (1.92e-1)" "unprognostic (8.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (2.77e-7)" "unprognostic (2.50e-2)" "unprognostic (1.61e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (3.12e-4)" 10.2 5.6 7.1 6.5 5.4 0.8 12.2 9.5 7.8 14.4 12.5 4.6 6.1 9.8 20.0 35.3 11.6 13.7 9.7 26.1 6.6 7.0 34.4 6.3 16.0 4.3 6.3 4.2 6.7 42.5 6.7 15.8 15.1 9.5 9.3 14.6 15.1 21.1 8.4 7.1 9.3 17.1 23.3 5.1 6.3 12.6 5.1 4.4 4.1 12.2 10.8 5.4 11.3 34.5 0.2 1.0 3.1 1.3 2.6 2.6 0.7 10.3 6.3 2.0 10.1 28.3 33.8 11.5 48.2 41.2 20.5 50.8 14.2 9.1 0.2 14.2 51.6 22.9 13.0 6.3 25.2 32.5 7.6 2.1 0.0 9.3 8.6 62.2 0.0 6.2 20.4 37.3 24.3 22.4 30.7 10.8 0.0 3.7 0.6 25.0 4.1 0.0 0.0 0.5 9.5 5.2 0.1 0.6 1.6 5.7 2.0 1.0 2.8 12.3 4.1 8.2 16.5 5.1 0.7 16.5 31.2 12.2 9.4 10.4 4.4 4.7 2.0 60.1 0.0 8.7 0.0 1.3 0.0 2.6 1.1 2.4 0.0 1.4 0.4 0.6 0.2 0.0 0.4 3.1 2.6 0.2 1.0 0.0 0.7 7.1 5.4 9.5 7.8 6.6 7.0 6.3 4.2 9.5 4.4 32.8 10.1 1.4 26.7 14.9 7.9 11.8 12.7 60.2 14.8 10.4 21.6 2.4 5.0 58.5 1.0 9.8 35.4 0.0 62.7 51.9 40.5 21.4 5.7 5.9 7.2 0.0 14.5 15.4 1.8 1.6 7.5 4.7 28.7 3.6 12.9 7.5 69.0 34.5 4.9 34.1 5.5 25.8 27.8 18.2 29.4 8.5 6.3 2.5 10.8 16.5 PDIA3 "ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC" ENSG00000167004 "Protein disulfide isomerase family A member 3" P30101 15 43746392-43773279 "Enzymes, Plasma proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 877.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002645, HPA003230, CAB011199, CAB015181, CAB075744" Enhanced Enhanced "Endoplasmic reticulum" "Intracellular and membrane" NA NA 390000000 "Endoplasmic reticulum" "CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: AB_2665750, HPA002645: AB_1079031, HPA003230: AB_1079030" "unprognostic (9.20e-2)" "unprognostic (1.21e-3)" "unprognostic (1.34e-1)" "prognostic favorable (2.05e-4)" "unprognostic (2.40e-2)" "prognostic unfavorable (8.95e-5)" "unprognostic (1.67e-1)" "unprognostic (8.60e-2)" "unprognostic (2.65e-1)" "unprognostic (2.24e-1)" "unprognostic (1.84e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.11e-8)" "unprognostic (1.82e-1)" "unprognostic (1.73e-1)" "unprognostic (1.19e-1)" "unprognostic (6.63e-2)" 16.9 21.2 10.0 20.5 13.5 20.8 31.1 12.7 9.2 24.7 19.4 12.3 33.9 22.2 19.7 42.4 21.7 18.4 25.1 20.6 10.2 12.7 27.3 112.5 20.0 34.6 12.4 10.3 22.4 46.8 21.1 21.7 44.0 13.3 24.6 21.2 13.7 43.4 36.9 8.7 17.9 28.8 15.8 11.4 25.2 20.5 17.1 14.3 15.6 74.0 16.4 19.8 14.7 28.3 7.7 18.3 13.5 10.8 11.7 14.1 14.5 12.3 4.6 9.8 21.9 19.9 21.4 30.1 24.7 24.5 18.4 22.9 12.9 12.7 14.1 16.1 28.2 12.3 19.7 12.4 24.0 16.1 10.2 18.4 19.1 7.4 11.9 32.8 10.7 13.9 13.7 19.9 13.9 23.5 21.7 32.0 4.5 11.0 6.9 17.9 4.2 3.6 12.2 9.9 19.0 18.7 7.1 15.4 10.6 15.7 10.1 9.9 11.0 20.6 19.8 7.8 10.4 13.8 11.0 21.6 15.3 8.1 12.3 12.0 3.2 3.6 14.8 19.6 17.0 11.5 10.0 10.3 13.5 13.4 10.5 14.1 6.5 8.5 10.8 9.6 7.7 7.2 8.4 2.9 11.7 10.8 18.3 6.7 14.5 10.0 13.5 12.7 9.2 10.2 12.7 12.4 10.3 13.3 14.3 178.6 134.5 154.1 249.6 170.7 50.3 49.5 142.7 231.6 287.8 158.7 39.3 559.5 59.7 337.0 18.9 151.7 227.1 23.3 345.2 636.6 296.9 292.3 254.2 280.2 396.2 66.7 178.5 269.5 152.1 20.5 234.7 267.6 231.2 285.9 259.4 139.7 260.6 167.0 260.3 106.7 46.2 122.9 160.2 185.1 135.1 129.7 877.1 174.3 233.4 256.5 PTPN1 PTP1B ENSG00000196396 "Protein tyrosine phosphatase, non-receptor type 1" P18031 20 50510321-50585241 "Enzymes, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 211.4;monocytes: 327.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009329, HPA012542, CAB015217" Approved Enhanced "Endoplasmic reticulum" NA NA 11000 "Endoplasmic reticulum" "CAB009329: AB_2174944, CAB015217: , HPA012542: AB_1855915" "unprognostic (1.67e-1)" "unprognostic (7.78e-2)" "unprognostic (1.48e-1)" "unprognostic (1.05e-2)" "unprognostic (1.14e-1)" "unprognostic (3.44e-2)" "unprognostic (2.98e-3)" "unprognostic (3.95e-2)" "unprognostic (2.40e-2)" "unprognostic (6.47e-3)" "unprognostic (5.87e-2)" "unprognostic (1.67e-1)" "unprognostic (1.66e-2)" "unprognostic (6.70e-2)" "unprognostic (2.99e-2)" "unprognostic (1.49e-1)" "unprognostic (2.58e-2)" 22.1 22.2 12.1 31.9 16.0 35.3 17.9 12.9 16.6 18.2 17.8 18.8 14.2 10.5 20.0 16.6 23.2 17.1 18.0 20.5 15.8 9.0 43.8 16.7 42.7 36.1 14.1 14.1 21.8 12.2 31.2 18.8 28.3 18.7 20.0 14.8 21.0 16.3 15.0 41.0 18.6 21.9 16.9 15.8 45.3 17.5 23.5 13.3 26.9 15.7 13.9 42.8 20.0 18.4 15.9 9.4 18.8 16.4 3.9 10.7 6.4 21.1 10.7 12.9 8.9 8.5 11.7 18.4 14.2 13.6 41.9 15.3 31.3 44.6 10.5 25.3 13.1 16.5 18.8 10.2 40.9 26.7 15.5 9.1 14.8 10.4 16.5 16.9 15.4 20.4 13.6 28.7 18.9 23.3 18.4 24.0 12.8 25.8 9.7 22.7 11.8 16.5 12.2 6.8 11.7 14.7 14.7 15.0 10.0 24.1 15.9 10.4 11.9 20.4 26.0 23.0 11.3 16.8 16.5 35.6 36.6 14.7 16.4 17.6 10.6 8.5 12.8 22.9 10.5 13.5 12.0 5.6 18.8 10.7 9.5 7.9 15.9 9.0 8.2 5.5 13.7 7.7 8.3 12.2 3.9 16.4 9.4 7.1 6.4 12.1 16.0 12.9 16.6 15.8 9.0 14.1 14.1 18.7 13.3 211.4 72.3 67.9 44.4 76.4 23.0 27.2 10.2 32.1 47.8 34.9 45.2 41.8 19.9 20.5 47.2 26.1 20.4 0.0 16.9 17.3 21.4 26.7 67.2 18.6 32.9 41.3 17.9 37.4 28.2 22.4 13.0 52.2 35.4 327.4 13.7 13.8 28.9 11.5 11.3 59.6 25.9 19.4 34.0 20.7 24.3 41.3 45.4 43.7 15.5 55.1 RCN2 "E6BP, ERC-55, ERC55, TCBP49" ENSG00000117906 "Reticulocalbin 2" Q14257 15 76931619-76954392 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 147.5" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 314.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030694, HPA030695" Enhanced Supported Enhanced "Endoplasmic reticulum" "Intracellular and membrane" NA NA 41000 "Endoplasmic reticulum" "HPA030694: AB_2673573, HPA030695: AB_2673574" "unprognostic (1.69e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-2)" "unprognostic (3.45e-2)" "unprognostic (2.42e-1)" "unprognostic (8.71e-2)" "prognostic unfavorable (7.36e-5)" "unprognostic (1.74e-1)" "unprognostic (2.20e-2)" "unprognostic (4.61e-3)" "unprognostic (1.39e-1)" "unprognostic (1.98e-1)" "unprognostic (1.70e-2)" "unprognostic (2.11e-2)" "unprognostic (2.99e-1)" "unprognostic (1.15e-1)" "unprognostic (3.67e-2)" 13.8 14.7 29.9 12.1 32.6 9.9 16.8 25.1 37.5 16.8 15.0 17.3 28.1 10.4 20.6 147.5 14.9 25.0 15.3 17.3 29.5 41.5 22.6 9.3 13.5 12.5 27.2 29.5 18.8 11.0 28.4 17.8 27.7 24.6 19.6 17.2 15.5 12.0 21.9 22.7 10.6 11.0 18.2 18.5 12.4 13.8 48.2 14.8 14.8 22.1 17.0 14.3 17.8 13.3 15.9 12.0 9.8 7.2 14.1 19.0 11.5 20.2 14.4 64.4 30.3 27.9 31.8 40.3 24.2 33.1 31.6 26.5 17.8 17.5 12.7 35.2 26.3 34.1 31.2 48.6 20.9 40.5 9.7 38.0 6.3 21.1 29.4 33.3 22.6 9.7 28.7 28.9 15.5 20.0 33.5 33.3 21.9 15.8 12.7 32.9 13.0 22.4 15.6 49.0 21.4 16.1 23.7 42.4 8.1 20.8 27.4 36.8 36.8 39.6 22.2 46.1 59.9 21.6 25.2 17.8 37.4 30.2 23.7 49.7 18.3 56.3 15.1 21.3 19.1 33.8 4.5 4.8 9.8 14.8 4.4 17.2 14.8 15.7 19.0 10.2 15.9 17.8 17.2 2.6 14.1 7.2 12.0 10.9 11.5 29.9 32.6 25.1 37.5 29.5 41.5 27.2 29.5 24.6 14.8 23.8 40.4 56.2 99.4 72.9 83.3 92.8 50.9 25.4 19.4 94.2 35.3 163.6 41.4 99.8 42.5 52.4 14.8 23.3 39.4 255.8 92.7 76.9 28.8 26.7 49.5 120.8 70.6 55.9 24.2 59.2 57.2 29.6 87.7 34.3 51.1 85.4 53.2 35.1 88.1 44.0 51.5 58.2 72.1 314.9 144.1 61.9 136.8 66.0 76.6 95.7 RPL10 "DXS648, DXS648E, FLJ23544, L10, NOV, QM" ENSG00000147403 "Ribosomal protein L10" P27635 X 154389955-154409168 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Developmental protein, Ribonucleoprotein, Ribosomal protein" "Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB010339, HPA011311" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA 130000 "Endoplasmic reticulum, Cytosol" "CAB010339: AB_2181277, HPA011311: AB_1856431" "unprognostic (2.46e-3)" "unprognostic (3.57e-2)" "unprognostic (1.72e-1)" "unprognostic (2.14e-2)" "unprognostic (1.25e-2)" "unprognostic (2.06e-1)" "unprognostic (6.11e-2)" "unprognostic (9.01e-3)" "unprognostic (1.91e-1)" "unprognostic (2.21e-1)" "unprognostic (5.39e-2)" "unprognostic (3.37e-1)" "prognostic unfavorable (7.67e-6)" "unprognostic (6.84e-2)" "unprognostic (1.86e-1)" "unprognostic (1.65e-2)" "unprognostic (5.68e-2)" 103.6 65.3 41.4 108.0 48.5 103.7 152.6 82.4 70.7 118.2 80.6 44.6 107.8 51.3 100.4 75.5 105.2 122.3 52.6 82.5 38.2 31.9 112.1 155.0 97.6 190.2 48.2 37.4 223.5 242.3 35.0 51.9 87.4 53.1 83.6 77.1 66.7 109.9 101.5 125.9 121.8 108.9 78.7 51.4 93.9 90.5 33.9 47.2 158.9 198.9 137.9 134.4 86.9 119.3 252.9 168.6 64.4 124.1 149.1 304.9 445.3 190.6 88.4 88.6 67.9 201.2 381.1 78.4 73.4 170.1 141.3 179.7 78.4 85.8 378.1 177.6 122.3 139.8 74.1 173.4 175.7 121.4 83.0 137.5 51.0 63.4 85.9 236.7 109.5 75.5 287.6 278.2 84.9 265.3 244.2 221.6 161.8 71.8 120.9 137.9 95.7 119.3 106.6 69.8 188.1 152.9 143.1 84.0 210.1 154.1 68.1 71.1 118.8 17.7 156.2 216.7 89.4 56.8 153.2 106.6 49.4 94.0 111.2 162.3 287.9 207.9 376.0 75.1 158.2 61.7 64.4 124.1 18.1 149.9 107.7 256.2 252.9 251.6 186.2 151.2 243.2 304.9 231.1 13.0 149.1 94.9 168.6 178.0 445.3 41.4 48.5 82.4 70.7 38.2 31.9 48.2 37.4 53.1 47.2 1664.5 2043.1 10322.4 11239.3 10721.6 451.7 309.0 3949.0 1271.5 2545.5 1934.9 233.7 5960.7 5721.4 3854.4 49.9 6113.6 2058.8 1915.6 11641.3 8484.3 6948.0 9869.1 2815.7 3204.1 6194.0 254.3 2785.1 5085.5 7653.2 131.8 7835.9 9465.3 7747.1 9437.5 6244.9 793.3 8332.0 5018.5 3353.3 5769.1 609.3 2942.7 9122.3 99.1 315.1 12724.6 6324.6 8194.7 7230.3 10693.0 RPL13 "BBC1, D16S444E, L13" ENSG00000167526 "Ribosomal protein L13" P26373 16 89560657-89566828 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051702 Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 53000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA051702: AB_2681579" "unprognostic (5.41e-3)" "unprognostic (1.69e-1)" "unprognostic (1.14e-2)" "prognostic favorable (6.26e-4)" "unprognostic (1.57e-2)" "unprognostic (3.68e-2)" "unprognostic (7.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.70e-1)" "unprognostic (1.44e-2)" "unprognostic (2.14e-1)" "unprognostic (7.57e-2)" "prognostic unfavorable (6.64e-4)" "unprognostic (4.34e-2)" "unprognostic (7.10e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" 82.5 56.0 46.7 105.0 38.4 112.7 150.9 37.7 44.0 114.5 114.9 31.3 76.9 65.5 118.4 85.4 144.0 98.4 101.6 85.2 38.6 32.1 60.8 118.3 90.4 385.1 38.8 37.4 231.3 255.8 36.5 57.5 66.0 27.0 136.2 44.4 43.0 267.3 87.6 197.4 137.7 66.7 90.2 44.8 104.7 71.1 106.5 24.6 135.0 102.4 129.6 98.6 109.3 156.8 277.8 163.1 26.9 96.9 120.7 299.0 355.4 67.5 75.1 53.4 86.5 96.1 160.2 111.9 42.7 92.6 89.3 36.3 113.4 104.8 95.0 88.2 72.4 35.5 94.0 63.4 112.3 44.6 26.6 176.0 32.3 41.9 150.3 205.8 39.2 39.5 194.0 239.4 57.2 144.3 145.7 93.0 120.4 98.7 54.2 68.5 211.6 107.4 308.2 109.2 133.6 79.9 160.2 56.6 133.5 108.4 56.8 75.3 110.2 59.1 77.3 128.1 35.2 152.0 233.4 54.2 57.7 62.3 50.8 58.5 82.2 77.2 96.9 75.3 138.7 60.5 26.9 96.9 15.3 129.1 74.9 239.2 252.5 234.3 176.5 116.8 277.8 299.0 230.2 10.7 120.7 56.7 163.1 163.7 355.4 46.7 38.4 37.7 44.0 38.6 32.1 38.8 37.4 27.0 24.6 1676.5 3076.1 8572.3 13242.6 11129.2 658.9 392.1 3263.7 1810.8 3433.9 1533.6 178.7 5497.3 3942.5 3304.0 3376.6 4985.3 2353.5 1588.5 9512.5 8594.0 5542.1 9230.0 2503.8 3991.9 4585.6 235.2 2827.6 3949.3 6200.5 9204.7 7634.3 6835.9 5176.0 5670.1 5289.2 713.9 6690.8 4380.2 3433.2 5399.2 577.3 2050.2 5882.2 1406.9 1082.9 14135.8 5156.1 7058.2 8155.8 12161.4 RPL24 L24 ENSG00000114391 "Ribosomal protein L24" P83731 3 101681091-101686782 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA051653 Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 19000 "Endoplasmic reticulum, Cytosol" "HPA051653: AB_2681564" "unprognostic (7.32e-2)" "unprognostic (2.11e-1)" "unprognostic (9.46e-2)" "unprognostic (1.78e-2)" "unprognostic (2.95e-3)" "unprognostic (1.22e-1)" "unprognostic (1.79e-3)" "unprognostic (2.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.29e-2)" "unprognostic (1.55e-1)" "unprognostic (7.43e-2)" "prognostic unfavorable (2.72e-5)" "unprognostic (4.98e-2)" "unprognostic (4.08e-1)" "prognostic favorable (8.25e-4)" "unprognostic (5.37e-2)" 61.3 58.9 60.6 99.3 68.8 87.9 135.5 73.0 90.1 94.7 64.0 15.8 84.3 49.6 74.2 98.0 75.5 65.4 82.9 110.0 45.6 43.8 58.3 70.3 122.0 256.0 50.7 46.3 174.7 211.4 25.9 65.5 68.2 53.4 69.0 54.7 30.4 133.9 109.9 175.9 66.2 46.2 98.7 80.7 51.4 60.5 30.2 44.1 61.3 84.7 134.3 71.7 105.1 175.4 128.2 107.7 29.6 65.6 85.5 173.8 214.1 165.3 55.0 84.4 93.1 92.6 165.8 127.7 95.3 106.6 129.0 94.5 109.4 73.3 182.5 118.4 72.9 51.6 88.1 97.7 118.2 129.2 97.8 98.0 108.2 47.8 81.8 91.0 121.6 57.3 160.9 151.6 81.1 145.0 127.7 109.1 88.3 99.0 91.1 118.6 110.6 129.7 186.4 151.8 150.8 119.5 114.4 83.3 174.3 131.6 73.9 180.7 84.0 49.7 89.3 211.5 75.5 109.1 223.9 79.7 56.3 104.4 30.7 115.9 80.1 102.2 319.2 75.4 128.8 94.2 29.6 65.6 16.3 86.1 57.1 125.2 128.2 136.4 104.2 90.5 127.0 173.8 132.3 10.9 85.5 56.9 107.7 121.1 214.1 60.6 68.8 73.0 90.1 45.6 43.8 50.7 46.3 53.4 44.1 881.4 1070.5 2163.1 2834.4 2028.6 247.2 305.0 1187.2 758.8 1325.1 579.3 80.5 1779.8 1921.5 1279.6 726.1 1676.7 912.8 607.3 2525.7 2622.3 1595.4 2203.5 1283.3 1194.7 1386.3 111.2 1311.9 1225.8 1564.2 477.7 2781.1 1768.0 1307.5 1765.6 1777.1 437.9 2399.6 1553.6 1411.5 2120.0 319.1 860.2 1451.3 472.4 280.9 2033.8 1958.3 1532.8 2167.1 2738.5 RPL27A L27A ENSG00000166441 "Ribosomal protein L27a" P46776 11 8682411-8714759 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 555.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060776, HPA063379" Supported Enhanced "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA060776: AB_2684359, HPA063379: AB_2684997" "prognostic favorable (7.84e-5)" "unprognostic (1.29e-1)" "unprognostic (1.60e-1)" "unprognostic (9.94e-3)" "unprognostic (3.16e-1)" "unprognostic (1.25e-1)" "unprognostic (1.90e-3)" "unprognostic (2.85e-1)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (1.69e-1)" "unprognostic (2.95e-1)" "prognostic unfavorable (2.83e-10)" "unprognostic (2.28e-2)" "unprognostic (6.87e-2)" "unprognostic (3.37e-2)" "unprognostic (7.68e-2)" 65.9 58.8 49.6 116.1 81.5 146.4 149.4 47.8 80.5 69.7 69.9 25.1 64.2 60.1 73.2 74.9 98.4 76.4 88.5 103.5 59.9 33.9 57.0 71.3 111.1 316.9 44.5 49.3 132.2 278.5 10.4 54.6 64.8 64.0 70.1 75.7 42.1 115.8 70.1 124.6 97.9 69.2 109.2 47.1 92.0 72.4 56.8 28.5 74.6 89.3 127.5 120.5 71.0 128.7 341.9 188.5 71.3 122.3 161.9 351.8 555.6 169.7 118.2 75.5 90.6 104.1 199.1 114.2 110.4 139.5 126.6 97.4 149.4 158.7 240.8 87.3 96.5 54.0 124.3 99.6 154.0 95.5 87.9 214.1 106.0 115.4 184.3 172.7 192.0 124.8 217.5 275.3 19.9 211.4 174.9 125.4 144.2 109.1 76.0 106.9 127.9 143.0 289.5 122.7 126.4 123.8 125.3 79.3 146.3 118.9 170.2 86.5 155.5 40.9 157.2 171.4 83.3 69.5 220.1 113.9 41.3 111.3 106.0 139.4 86.6 189.8 197.0 94.8 131.6 74.8 71.3 122.3 37.8 208.1 119.1 266.8 341.9 295.7 244.4 188.5 301.2 351.8 290.3 29.7 161.9 108.1 180.0 198.2 555.6 49.6 81.5 47.8 80.5 59.9 33.9 44.5 49.3 64.0 28.5 1042.2 1639.1 5447.5 5197.7 4315.3 211.8 780.0 2010.1 1169.7 2127.0 936.9 108.0 4955.4 2420.5 2120.6 640.6 2975.9 1990.9 1378.3 4688.2 6270.1 2784.5 3963.3 2012.4 2288.9 3821.7 76.3 2038.1 2441.8 3815.0 1497.4 3355.1 4578.8 2687.5 3973.9 4593.3 390.8 4009.3 4780.0 1839.6 2272.7 251.4 1532.8 3189.9 395.7 439.9 5297.8 5030.9 4388.7 5800.0 5583.1 RPN1 OST1 ENSG00000163902 "Ribophorin I" P04843 3 128619970-128681075 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009748, HPA026828, HPA051520" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA 8200000 "Endoplasmic reticulum" Cytosol "CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521" "unprognostic (4.83e-2)" "unprognostic (5.92e-2)" "unprognostic (1.10e-1)" "unprognostic (7.67e-2)" "unprognostic (2.36e-1)" "unprognostic (2.12e-2)" "prognostic unfavorable (4.80e-4)" "unprognostic (2.71e-1)" "unprognostic (2.43e-1)" "unprognostic (2.28e-2)" "unprognostic (4.58e-3)" "unprognostic (2.87e-1)" "unprognostic (7.68e-2)" "unprognostic (7.86e-2)" "unprognostic (1.52e-2)" "unprognostic (1.44e-1)" "unprognostic (9.74e-2)" 52.3 37.5 22.2 26.6 23.8 24.4 48.2 20.9 31.4 45.8 40.8 31.9 58.8 28.5 38.3 110.2 32.2 38.3 38.8 47.1 23.0 28.0 55.4 174.0 47.4 50.6 26.4 18.3 37.8 62.9 43.5 36.9 58.3 24.3 31.4 41.1 28.6 54.1 55.5 34.4 24.0 37.0 33.5 31.8 48.0 33.7 26.9 23.3 34.3 69.1 27.3 36.5 32.7 39.7 26.7 53.1 64.4 43.5 23.4 45.1 53.3 60.5 33.0 27.6 50.7 74.7 50.1 62.5 52.2 68.7 69.4 80.9 68.4 57.1 37.9 49.3 75.3 64.7 61.0 44.5 46.5 68.0 27.2 28.6 66.8 24.6 56.2 82.4 54.2 35.2 41.5 54.4 45.6 67.5 46.5 54.2 28.7 27.5 50.9 45.5 55.4 30.0 59.6 35.0 81.1 30.3 32.9 37.1 91.2 48.1 36.4 42.5 24.5 42.9 44.5 52.8 36.9 47.6 56.1 35.2 35.9 28.1 52.5 38.7 54.9 43.2 40.5 58.9 40.4 51.8 38.8 43.5 35.7 37.3 40.0 45.1 26.7 30.7 33.8 43.5 18.3 19.1 29.2 64.4 23.4 40.2 53.1 30.5 53.3 22.2 23.8 20.9 31.4 23.0 28.0 26.4 18.3 24.3 23.3 56.6 71.5 37.3 71.3 44.0 11.5 35.3 61.1 66.9 47.8 106.4 7.9 108.3 13.3 99.9 13.7 58.2 107.9 46.7 81.2 161.1 79.3 88.0 42.7 155.3 122.7 19.1 41.6 107.4 134.1 20.7 87.2 73.4 55.6 36.9 102.4 27.5 98.9 83.4 60.5 80.2 11.7 45.3 39.6 49.9 59.8 46.7 131.0 50.0 106.2 66.4 RPS16 S16 ENSG00000105193 "Ribosomal protein S16" P62249 19 39433207-39435948 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064222 Approved Enhanced "Endoplasmic reticulum,Cytosol" No No 36000 "Endoplasmic reticulum, Cytosol" "HPA064222: AB_2685218" "unprognostic (4.63e-3)" "unprognostic (4.78e-2)" "unprognostic (2.73e-1)" "unprognostic (9.49e-2)" "unprognostic (2.20e-2)" "unprognostic (1.53e-1)" "unprognostic (1.62e-2)" "unprognostic (8.89e-2)" "unprognostic (2.96e-1)" "unprognostic (1.89e-3)" "unprognostic (4.40e-2)" "unprognostic (5.28e-2)" "unprognostic (5.73e-3)" "unprognostic (1.82e-1)" "unprognostic (1.69e-2)" "unprognostic (2.06e-1)" "unprognostic (4.62e-2)" 89.8 60.8 49.0 123.2 46.1 127.3 126.9 39.8 46.8 124.8 120.7 48.6 80.0 67.2 97.9 80.8 150.1 108.1 105.9 118.7 41.7 35.7 81.5 147.6 103.7 243.2 49.2 29.9 248.1 457.6 19.9 48.8 97.0 35.5 129.5 52.8 73.8 130.5 87.6 205.5 113.4 110.9 126.3 52.2 136.7 92.1 57.4 37.7 153.9 125.1 183.6 151.0 143.8 159.8 153.7 106.4 17.6 71.8 71.7 179.1 225.5 138.9 297.8 80.0 90.7 120.5 148.7 74.3 64.1 75.0 83.8 77.2 189.4 77.2 117.8 83.2 79.9 31.8 46.4 93.6 155.9 53.0 137.6 221.5 93.0 101.4 195.7 123.1 135.7 63.1 173.4 243.1 73.8 117.9 114.0 107.3 152.3 118.7 133.3 87.3 214.7 185.4 136.9 98.8 176.8 109.0 124.3 82.7 142.4 91.9 156.9 81.5 117.2 48.1 216.7 164.7 56.2 62.1 263.7 64.5 69.9 91.6 74.0 139.4 185.8 192.2 149.3 72.3 129.9 67.4 17.6 71.8 11.0 84.5 57.9 120.9 153.7 140.8 105.6 91.9 143.2 179.1 143.0 13.2 71.7 48.2 106.4 94.7 225.5 49.0 46.1 39.8 46.8 41.7 35.7 49.2 29.9 35.5 37.7 1051.1 1483.9 3949.0 3037.8 3456.7 300.0 882.4 2025.5 1279.5 2023.5 772.9 182.6 3919.4 1871.8 1658.2 460.7 2103.8 1281.1 1471.8 3703.3 5212.0 2075.3 2629.1 1071.8 2095.9 2461.9 108.1 1421.1 1433.3 2612.0 1078.8 3908.0 3281.4 1931.7 3389.6 2360.5 436.5 2661.2 1690.0 1746.6 2505.6 404.4 1261.2 2305.1 506.0 777.6 3962.5 3964.9 2423.2 3346.2 3508.5 RPS23 S23 ENSG00000186468 "Ribosomal protein S23" P62266 5 82273358-82278577 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054853 Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 130000 "Endoplasmic reticulum, Cytosol" "HPA054853: AB_2682625" "unprognostic (1.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (2.70e-2)" "unprognostic (1.28e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (6.61e-2)" "unprognostic (5.80e-2)" "unprognostic (2.24e-1)" "unprognostic (8.29e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.17e-4)" "unprognostic (3.87e-2)" "unprognostic (6.47e-2)" "unprognostic (2.22e-1)" "unprognostic (1.67e-1)" 114.6 62.1 72.6 129.7 54.8 139.2 191.8 45.1 53.7 141.2 118.9 46.5 83.5 62.2 131.8 94.1 145.2 118.3 114.4 79.4 61.4 52.9 92.8 134.8 90.1 200.7 74.4 34.7 269.5 211.6 41.6 65.6 94.6 51.9 134.3 89.8 52.9 126.7 84.7 205.4 134.3 97.0 129.6 77.7 150.1 83.8 61.4 51.5 194.5 141.5 171.9 173.8 160.7 165.8 140.7 110.8 11.1 56.6 63.8 136.1 158.2 92.5 36.5 105.3 80.7 177.2 239.7 107.3 89.0 134.9 134.6 134.0 51.2 63.3 218.4 62.4 115.1 83.5 47.7 157.3 255.9 139.9 79.2 88.8 89.3 54.1 49.7 234.1 128.9 64.9 230.0 304.6 102.7 269.9 202.2 173.4 139.1 92.8 68.8 116.2 60.2 142.0 130.9 67.3 49.6 85.1 95.2 150.8 196.3 130.7 39.2 67.7 88.5 45.8 79.8 180.2 109.7 60.6 200.0 123.0 19.2 74.8 46.7 139.7 99.0 144.6 153.5 45.4 167.0 42.1 11.1 56.6 8.7 60.1 52.4 92.2 140.7 103.0 81.1 97.6 130.8 136.1 112.3 6.0 63.8 43.3 110.8 73.4 158.2 72.6 54.8 45.1 53.7 61.4 52.9 74.4 34.7 51.9 51.5 988.6 1141.9 5759.9 4914.2 5245.2 367.5 259.5 2438.2 829.8 1736.9 1080.0 163.0 4238.7 3231.3 2015.9 794.6 3082.6 1557.8 1238.1 4142.3 6097.5 3274.2 3882.5 1615.9 2361.6 3614.8 220.9 1831.3 2502.0 3505.0 1289.5 5717.9 4715.7 2717.9 3404.0 3317.6 563.2 3460.3 2745.9 2903.9 4001.7 470.7 1675.1 2898.4 786.8 872.2 6212.4 4350.9 3718.5 5163.2 5114.9 RPS24 S24 ENSG00000138326 "Ribosomal protein S24" P62847 10 78033732-78056813 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003364, HPA073508" Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 70000 "Endoplasmic reticulum, Cytosol" "HPA003364: AB_1079847, HPA073508: " "prognostic favorable (1.50e-4)" "unprognostic (1.58e-1)" "unprognostic (4.95e-2)" "unprognostic (1.09e-1)" "unprognostic (6.95e-2)" "unprognostic (8.01e-3)" "unprognostic (3.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.25e-1)" "unprognostic (9.48e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.10e-10)" "unprognostic (3.18e-2)" "unprognostic (1.38e-1)" "unprognostic (6.65e-2)" "unprognostic (8.22e-2)" 171.6 122.0 127.7 80.8 79.0 186.2 231.3 56.2 68.4 242.4 201.1 37.9 112.4 86.2 159.2 148.8 277.8 125.1 128.5 123.9 90.4 83.8 134.4 176.6 147.0 263.8 100.6 70.2 369.4 279.3 49.1 86.1 139.3 64.6 251.6 130.0 49.8 176.0 139.5 320.4 192.3 148.9 182.4 111.7 175.8 85.3 87.9 79.5 197.1 221.4 130.0 123.5 271.7 237.7 171.5 180.5 49.6 123.2 156.4 187.3 213.6 111.1 43.4 109.4 170.7 135.6 239.4 98.6 119.5 164.6 126.3 111.1 62.5 78.5 231.0 65.7 103.3 43.9 86.6 126.0 154.0 115.9 76.9 142.8 94.1 28.9 59.5 153.8 224.8 53.6 226.9 230.8 89.3 324.4 254.4 149.9 99.2 127.6 46.3 136.1 45.3 119.9 370.7 76.7 199.9 406.5 81.5 130.9 111.0 161.2 52.2 55.3 108.3 60.1 202.3 147.6 119.9 114.0 249.9 127.0 38.3 91.3 51.9 158.0 60.9 123.1 178.1 47.3 313.4 31.3 49.6 123.2 46.5 102.4 118.3 167.4 171.5 140.6 129.8 180.5 145.4 187.3 168.2 16.9 156.4 91.0 155.4 112.3 213.6 127.7 79.0 56.2 68.4 90.4 83.8 100.6 70.2 64.6 79.5 690.8 1269.5 3209.8 4202.0 3647.0 323.7 537.2 1994.9 927.5 1705.0 760.7 102.1 2994.5 2778.6 1946.3 1157.3 2319.7 1458.1 1097.9 3916.2 5172.5 2049.1 2966.1 1188.1 1848.0 2894.9 143.0 2011.7 1935.4 4187.3 3507.5 5250.7 4018.5 1926.6 2732.2 3111.1 529.6 2893.5 2823.1 2432.9 2781.3 330.7 1248.2 2260.6 575.1 551.3 4012.4 2962.0 2362.2 4939.3 4132.1 RPS26 S26 ENSG00000197728 "Ribosomal protein S26" P62854 12 56041351-56044676 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043961, HPA055803" Uncertain Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA043961: AB_10963579, HPA055803: AB_2682927" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (3.36e-1)" "unprognostic (9.58e-2)" "unprognostic (3.74e-1)" "unprognostic (7.84e-3)" "unprognostic (1.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.25e-1)" "unprognostic (3.76e-2)" "unprognostic (2.49e-1)" "unprognostic (3.03e-1)" "unprognostic (2.06e-2)" "unprognostic (1.41e-1)" "unprognostic (4.40e-2)" "unprognostic (2.18e-1)" "unprognostic (7.99e-2)" 36.5 66.6 33.3 29.0 48.8 39.2 49.7 23.8 73.7 44.5 45.6 34.9 20.5 20.0 35.9 50.4 49.9 43.5 28.4 39.8 25.8 24.8 61.8 154.3 29.5 56.0 31.4 26.2 75.8 80.4 25.6 29.7 28.7 45.1 35.4 49.1 28.5 38.0 41.1 62.2 50.9 57.5 36.9 30.0 51.6 40.3 47.0 32.5 47.3 58.4 60.0 78.4 46.7 41.2 93.0 69.8 29.8 42.8 63.6 107.4 108.8 53.4 65.8 75.0 27.8 103.9 154.2 75.2 54.5 81.0 90.9 53.2 101.0 24.2 119.3 34.5 57.5 30.0 25.2 84.2 46.9 62.3 47.2 135.1 63.0 43.9 60.2 96.0 40.9 34.6 93.3 150.3 47.9 54.6 35.9 69.0 85.6 42.9 39.8 73.5 82.9 30.6 74.3 73.6 65.4 149.1 41.7 22.5 73.4 75.9 54.2 28.2 48.8 21.3 47.2 30.9 23.3 41.7 45.8 22.3 22.6 46.3 28.8 43.7 34.3 65.6 64.4 25.1 81.7 28.9 29.8 41.4 27.1 74.6 42.8 83.8 93.0 97.8 81.8 55.3 79.8 107.4 99.3 17.0 63.6 38.2 69.8 101.7 108.8 33.3 48.8 23.8 73.7 25.8 24.8 31.4 26.2 45.1 32.5 208.4 201.5 1424.8 560.8 1563.9 119.2 23.8 1184.7 333.3 536.9 408.2 58.9 1212.8 824.0 801.2 63.2 800.7 1808.5 1004.5 2275.1 2554.3 1158.0 914.2 500.2 1753.2 1234.1 71.5 826.4 935.4 838.0 37.7 273.5 701.1 1386.7 874.7 1010.7 278.9 1348.0 1392.2 208.2 969.4 134.7 304.0 900.2 204.7 313.7 1585.9 1428.5 824.9 1127.8 1109.2 RPS3A "MFTL, S3A" ENSG00000145425 "Ribosomal protein S3A" P61247 4 151099573-151104652 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" Differentiation "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 440.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047100, HPA053454" Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" No No 63000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA047100: AB_2679931, HPA053454: AB_2682156" "unprognostic (6.24e-3)" "unprognostic (3.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.16e-1)" "unprognostic (1.79e-2)" "unprognostic (5.46e-2)" "prognostic unfavorable (6.56e-4)" "unprognostic (1.17e-1)" "unprognostic (1.16e-2)" "unprognostic (1.01e-1)" "unprognostic (6.41e-2)" "unprognostic (1.27e-1)" "unprognostic (6.81e-3)" "unprognostic (2.36e-1)" "unprognostic (1.96e-1)" "unprognostic (2.00e-1)" "unprognostic (3.39e-1)" 71.7 46.9 48.4 69.2 47.7 124.7 160.3 40.4 43.5 114.1 98.4 30.4 61.9 45.0 75.3 84.4 142.8 73.3 53.9 51.1 36.8 33.3 72.8 94.2 79.4 102.5 42.6 43.5 179.5 143.8 18.1 49.3 70.5 38.0 113.3 62.4 39.0 113.8 48.5 116.8 97.1 73.5 62.0 43.1 94.2 64.2 61.9 30.7 120.4 126.8 111.6 90.6 111.4 86.3 211.6 187.7 44.3 92.8 142.9 282.7 440.7 80.5 59.3 113.1 111.1 145.6 285.0 115.5 85.9 132.7 121.8 75.4 114.6 117.8 365.6 43.0 93.6 43.0 53.5 114.6 143.5 115.8 80.5 110.9 78.9 73.3 132.3 168.6 187.3 81.9 211.3 296.1 74.9 199.3 172.0 144.4 137.0 126.9 191.5 144.6 120.4 202.3 222.6 106.1 129.0 45.9 148.2 110.4 122.3 141.0 97.9 108.8 107.7 38.6 141.4 189.2 83.4 94.6 227.8 87.6 59.6 78.9 65.7 94.5 148.9 239.5 223.9 76.5 136.8 70.6 44.3 92.8 27.2 120.6 74.5 203.9 211.6 203.1 157.9 156.5 185.7 282.7 226.9 15.1 142.9 62.1 187.7 145.5 440.7 48.4 47.7 40.4 43.5 36.8 33.3 42.6 43.5 38.0 30.7 902.2 1351.4 4981.2 6887.5 5470.3 389.5 334.4 1689.1 1088.1 1918.8 783.4 113.9 3954.4 3630.9 1946.8 1331.3 2405.0 1231.3 1425.0 3246.4 6519.9 2822.1 4092.8 1400.9 1318.9 2985.4 154.1 2072.9 2006.5 3842.5 3230.8 4100.5 4536.3 3092.4 3236.3 3439.0 634.6 3016.2 2304.0 2436.9 3691.6 432.9 1739.7 3595.7 655.4 688.2 5905.5 3840.1 4239.4 5672.4 6561.2 RPS6 S6 ENSG00000137154 "Ribosomal protein S6" P62753 9 19375715-19380254 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 584.2" "Low region specificity" "Detected in all" "CAB004027, HPA031153" Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 100000 "Endoplasmic reticulum, Cytosol" "CAB004027: AB_2238583, HPA031153: AB_10602245" "unprognostic (3.95e-3)" "unprognostic (2.08e-1)" "unprognostic (6.34e-2)" "prognostic favorable (4.12e-4)" "unprognostic (1.63e-2)" "unprognostic (1.22e-2)" "unprognostic (1.36e-2)" "unprognostic (6.61e-2)" "unprognostic (8.16e-2)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" "unprognostic (2.76e-1)" "unprognostic (1.90e-2)" "unprognostic (1.68e-1)" "unprognostic (1.02e-1)" "unprognostic (8.36e-3)" "unprognostic (2.06e-3)" 90.0 65.3 64.1 110.2 70.2 166.3 152.8 37.0 50.4 125.4 149.9 38.8 57.4 73.0 91.6 97.7 166.8 87.7 81.5 70.0 51.5 44.4 88.5 91.3 104.0 243.5 66.0 36.2 206.6 441.2 26.1 64.0 67.9 64.7 152.5 83.9 53.3 109.1 72.1 129.5 139.9 96.3 157.8 84.5 137.8 87.5 67.2 53.2 127.9 147.0 119.7 125.8 207.4 143.4 237.2 135.7 30.1 75.5 129.7 274.9 399.9 108.2 71.2 72.4 84.8 122.8 189.6 87.0 73.2 95.6 88.0 73.7 59.2 50.2 249.0 72.5 69.9 31.2 53.3 81.1 112.7 95.7 129.7 77.6 164.1 92.2 107.3 150.0 86.9 82.0 157.2 206.1 58.6 172.9 126.7 105.8 112.5 68.9 101.6 94.9 65.2 184.0 584.2 135.8 86.0 48.5 144.1 73.3 118.4 121.8 93.2 72.4 97.4 27.7 118.0 151.3 60.7 76.8 317.7 77.5 50.7 54.3 52.4 114.4 48.1 93.1 169.0 34.3 130.7 29.6 30.1 75.5 23.3 111.6 67.1 193.2 237.2 205.0 150.5 135.7 196.8 274.9 215.8 12.8 129.7 60.6 126.1 152.7 399.9 64.1 70.2 37.0 50.4 51.5 44.4 66.0 36.2 64.7 53.2 1536.5 2830.0 6502.2 11967.4 8648.0 283.0 709.9 2662.4 2307.4 4835.2 1210.9 119.8 4727.3 4907.4 2480.2 2006.9 4335.8 1389.0 2149.2 5906.0 7578.1 3573.8 7361.0 3033.7 1998.6 3545.0 71.5 1975.3 3407.3 3797.3 4913.1 4288.0 4784.3 4367.8 4093.0 4198.5 516.9 4659.6 3594.7 2278.1 5890.0 305.7 1461.7 5142.7 1143.2 654.9 10561.7 4523.6 5315.7 7244.9 10415.6 RPS8 S8 ENSG00000142937 "Ribosomal protein S8" P62241 1 44775251-44778779 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029266 Enhanced "Endoplasmic reticulum,Cytosol" NA NA 52000 "Endoplasmic reticulum, Cytosol" "HPA029266: AB_10601611" "unprognostic (9.70e-3)" "unprognostic (2.26e-1)" "unprognostic (3.02e-1)" "unprognostic (9.75e-2)" "unprognostic (1.62e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.36e-5)" "unprognostic (1.02e-1)" "unprognostic (6.17e-2)" "unprognostic (7.30e-2)" "unprognostic (9.31e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (9.05e-9)" "unprognostic (1.94e-1)" "unprognostic (8.55e-2)" "unprognostic (8.83e-2)" "unprognostic (5.57e-2)" 55.7 60.7 44.8 44.4 46.3 100.1 82.0 50.1 65.5 69.6 47.8 33.8 37.0 40.7 61.9 48.4 78.0 66.7 43.9 36.8 34.6 23.7 41.6 74.1 36.5 77.7 34.8 34.6 195.0 98.3 13.1 37.2 45.4 36.8 53.5 42.5 32.3 61.0 72.7 53.7 91.2 45.6 39.4 35.6 57.0 47.4 71.9 29.0 64.8 40.9 97.3 72.0 52.7 71.2 146.1 98.0 15.3 50.2 61.2 128.4 168.5 102.3 51.3 82.4 108.5 143.3 225.6 134.8 75.3 119.5 106.5 85.7 87.9 112.1 194.1 83.1 91.2 68.6 70.3 105.6 131.1 78.8 70.2 184.5 72.3 73.0 116.8 203.7 143.7 71.0 179.4 217.6 70.9 190.6 153.6 127.2 117.8 107.4 136.5 99.0 81.0 157.9 153.8 180.0 86.4 88.8 127.3 100.9 216.6 119.5 88.1 88.2 101.8 40.7 228.4 298.5 83.3 79.8 289.3 86.7 53.0 92.9 81.2 127.8 107.8 105.6 146.7 64.8 172.7 63.4 10.3 50.2 15.3 55.1 49.1 94.1 146.1 101.4 76.7 79.2 124.5 128.4 106.7 5.0 61.2 38.1 98.0 84.2 168.5 44.8 46.3 50.1 65.5 34.6 23.7 34.8 34.6 36.8 29.0 1316.1 1723.1 6218.3 8263.7 7023.7 212.5 618.5 2667.5 1619.4 2842.4 1036.4 86.4 4856.6 3516.4 2080.0 402.3 3276.6 1407.7 2826.7 5263.3 6516.1 3553.3 5089.6 1744.1 1895.9 3113.3 57.2 2060.2 2974.6 3941.2 529.4 5688.8 4066.1 2795.5 3230.1 3644.2 416.1 4072.9 3794.5 2586.4 2671.8 154.0 1481.1 4301.1 393.8 413.6 9798.1 4485.5 3459.3 5777.2 7011.6 RRBP1 "ES/130, hES" ENSG00000125844 "Ribosome binding protein 1" Q9P2E9 20 17613678-17682295 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 136.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 18.8;plasmacytoid DC: 23.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009026, HPA011924" Enhanced Enhanced "Endoplasmic reticulum" NA NA 44000 "Endoplasmic reticulum" "HPA009026: AB_1079852, HPA011924: AB_1856476" "unprognostic (1.56e-3)" "unprognostic (2.26e-3)" "unprognostic (8.46e-2)" "prognostic favorable (1.41e-4)" "unprognostic (1.04e-1)" "unprognostic (1.05e-1)" "unprognostic (2.92e-2)" "unprognostic (2.21e-1)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-2)" "unprognostic (3.03e-1)" "unprognostic (5.09e-2)" "unprognostic (6.63e-2)" "unprognostic (9.21e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.38e-4)" 19.9 18.3 6.7 16.1 11.2 5.9 13.8 4.9 7.4 22.1 23.6 17.8 49.5 18.5 16.3 24.4 17.1 12.3 37.3 15.8 7.8 6.3 27.1 88.9 20.5 10.6 13.0 5.6 23.4 136.1 24.7 18.4 51.4 10.4 19.4 16.7 14.8 84.2 56.0 7.7 11.0 32.2 13.0 13.3 20.4 30.0 12.1 12.2 5.0 32.8 11.6 19.2 18.7 18.9 0.9 23.5 18.8 4.7 5.7 2.5 1.5 30.4 21.7 6.5 14.6 30.1 32.7 34.4 47.8 40.2 20.2 27.5 48.3 28.8 11.8 16.1 45.1 20.9 30.7 7.0 38.8 16.6 5.4 5.4 13.6 6.3 49.8 43.3 5.0 17.2 43.1 11.7 32.7 19.4 30.0 19.9 4.2 5.6 11.5 30.3 13.8 1.9 11.5 7.6 67.9 21.0 3.5 17.3 40.5 17.1 10.4 3.3 2.5 27.2 64.6 19.6 14.5 11.3 7.7 35.7 43.3 16.1 22.4 15.7 21.1 16.0 3.9 16.4 5.4 22.0 5.4 4.7 18.8 2.5 2.9 1.7 0.5 0.8 1.4 2.4 0.9 0.8 0.9 4.2 5.7 4.0 23.5 0.7 1.5 6.7 11.2 4.9 7.4 7.8 6.3 13.0 5.6 10.4 12.2 89.3 202.0 34.3 70.6 52.5 17.0 30.9 147.7 131.2 145.6 90.7 29.5 233.8 38.1 171.5 35.2 132.5 313.0 0.0 359.4 194.5 183.3 135.6 113.5 227.0 102.0 23.8 93.1 135.1 51.8 28.3 117.6 73.6 67.4 86.6 259.3 193.4 291.3 208.5 78.1 62.7 35.4 32.3 138.2 74.8 93.6 48.8 445.7 36.3 168.2 180.5 RTN1 NSP ENSG00000139970 "Reticulon 1" Q16799 14 59595976-59870966 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 144.6" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 227.2" "Cancer enhanced" "Detected in many" "glioma: 19.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9" "Group enriched" "Detected in many" 15 "dendritic cells: 7.9;monocytes: 4.6" "Group enriched" "Detected in some" 4 "HEL: 23.2;SCLC-21H: 28.7;SH-SY5Y: 46.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002745, HPA040945, HPA044249" Enhanced Supported "Nuclear bodies,Endoplasmic reticulum" NA NA 140000 "Endoplasmic reticulum" "Nuclear bodies" "CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874" "unprognostic (9.40e-3)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (4.24e-2)" "unprognostic (3.04e-3)" "unprognostic (8.67e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (2.79e-1)" "prognostic favorable (3.69e-4)" "unprognostic (5.79e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.75e-1)" "unprognostic (6.71e-2)" "unprognostic (1.62e-2)" 6.3 8.3 27.4 6.1 46.3 1.6 3.0 98.5 144.6 2.6 2.9 11.0 0.0 2.7 2.1 1.6 2.3 8.6 4.4 1.9 32.3 50.7 2.3 1.9 4.8 2.7 21.3 45.9 1.7 3.6 19.2 10.3 2.7 35.1 5.0 3.0 1.2 2.3 2.6 1.6 2.3 3.4 2.7 12.1 10.6 3.6 2.6 10.5 0.0 2.7 0.0 2.3 2.5 0.9 0.0 7.9 0.4 4.6 0.0 0.0 1.0 0.0 0.0 0.3 0.4 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.8 23.2 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 28.7 46.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 3.9 1.1 0.0 2.1 0.0 0.0 0.0 7.7 1.6 0.2 0.0 4.5 0.0 0.0 4.6 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 1.0 27.4 46.3 98.5 94.7 32.3 50.7 21.3 45.9 35.1 10.5 0.0 0.6 0.0 0.4 4.2 26.8 0.8 2.5 1.4 1.2 0.0 23.6 0.8 0.0 0.0 13.2 0.5 0.2 0.0 0.0 0.7 2.1 6.2 0.0 0.4 15.8 227.2 51.9 0.0 15.9 14.4 2.6 24.4 10.1 1.8 0.0 13.1 2.2 0.0 1.1 0.3 29.4 0.0 2.1 2.1 2.5 5.6 2.1 0.0 0.2 0.3 RTN4 "ASY, KIAA0886, NOGO, NSP-CL" ENSG00000115310 "Reticulon 4" Q9NQC3 2 54972187-55112621 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Muller glia cells: 3179.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 159.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005388, HPA023977" Supported Enhanced "Endoplasmic reticulum" NA NA 13000000 "Endoplasmic reticulum" "CAB005388: AB_2285559, HPA023977: AB_2671391" "unprognostic (1.31e-2)" "unprognostic (1.71e-3)" "unprognostic (6.76e-2)" "unprognostic (1.28e-3)" "unprognostic (1.24e-3)" "prognostic unfavorable (1.00e-4)" "unprognostic (5.79e-2)" "unprognostic (1.84e-3)" "unprognostic (2.47e-1)" "unprognostic (1.97e-1)" "unprognostic (3.91e-3)" "unprognostic (4.38e-1)" "unprognostic (4.41e-2)" "unprognostic (1.29e-2)" "unprognostic (4.99e-2)" "unprognostic (1.27e-1)" "unprognostic (4.91e-2)" 103.7 60.5 75.1 27.9 85.0 19.3 63.6 66.6 105.5 24.8 35.4 52.9 17.5 45.0 29.3 36.0 43.0 26.3 38.5 30.8 71.9 69.7 86.5 103.5 36.2 19.6 84.9 75.8 27.4 23.7 59.9 16.1 33.8 99.0 45.2 35.7 24.7 23.6 38.1 171.1 48.1 55.2 47.4 92.6 20.1 23.5 14.6 62.7 14.7 25.9 47.2 16.5 48.1 35.4 2.8 6.1 33.3 7.7 16.8 15.8 4.4 33.0 24.0 23.5 6.1 80.1 75.2 13.2 110.1 93.6 34.1 31.9 19.7 31.5 7.2 58.6 74.6 57.1 30.1 15.4 44.3 52.1 20.4 11.8 9.9 14.8 31.1 159.5 17.8 5.1 56.3 42.4 46.6 90.9 68.9 63.9 18.3 20.2 16.7 147.0 9.6 21.7 18.2 21.1 7.2 21.5 9.7 31.0 14.9 79.1 39.9 15.5 18.3 25.2 14.8 30.8 42.1 12.6 13.7 90.6 66.7 28.3 26.2 62.9 10.2 8.2 4.6 67.9 20.7 53.6 33.3 4.3 10.9 4.3 4.9 3.5 2.8 6.9 3.8 4.0 1.6 11.7 4.8 7.0 16.8 7.7 6.1 15.8 4.4 75.1 85.0 66.6 105.5 71.9 69.7 84.9 75.8 99.0 62.7 163.8 161.9 100.2 1062.9 943.4 647.1 108.1 226.7 159.3 127.4 642.0 357.4 421.2 247.1 487.4 360.7 341.8 464.3 70.0 283.5 513.5 379.7 775.3 148.7 573.6 570.9 402.0 213.0 178.0 338.1 193.3 155.1 405.6 323.9 461.7 231.2 3179.0 405.8 189.0 212.5 568.0 465.4 213.4 311.0 240.3 85.0 925.9 302.8 121.8 187.3 1082.8 SCD "FADS5, SCDOS" ENSG00000099194 "Stearoyl-CoA desaturase" O00767 10 100347124-100364834 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 300.1;Hepatocytes: 153.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 204.0;CAPAN-2: 141.3" "Low region specificity" "Detected in all" "HPA012107, HPA063921" Approved Enhanced "Endoplasmic reticulum" No Yes "Endoplasmic reticulum" "HPA012107: AB_1856610, HPA063921: AB_2685154" "unprognostic (2.10e-1)" "unprognostic (2.62e-3)" "unprognostic (7.86e-2)" "unprognostic (5.19e-2)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "unprognostic (1.13e-1)" "unprognostic (3.88e-2)" "unprognostic (6.53e-2)" "unprognostic (2.72e-1)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (7.56e-5)" "unprognostic (7.18e-2)" "unprognostic (3.27e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (7.79e-5)" 245.0 21.3 59.8 11.4 32.7 5.5 94.0 12.7 83.9 5.3 10.8 63.6 0.1 21.4 3.7 7.0 13.4 1.7 18.3 109.2 61.5 43.4 5.0 130.8 32.2 23.1 65.1 23.6 12.7 6.1 7.7 1.5 5.3 34.5 24.4 10.1 4.5 24.9 3.7 2.4 3.4 6.1 4.6 130.0 4.2 5.9 12.2 35.4 1.4 2.0 6.9 5.4 3.7 5.0 2.0 5.3 0.2 3.3 2.9 5.1 2.1 31.0 28.6 61.1 41.9 204.0 117.7 12.5 3.3 73.7 8.0 42.8 24.6 141.3 13.1 2.6 7.8 36.6 55.6 33.6 119.4 7.0 4.4 13.9 7.3 18.2 49.2 39.4 10.2 8.0 64.0 36.2 31.1 54.8 21.6 15.2 29.1 20.4 40.1 3.2 48.6 11.6 12.2 21.2 9.1 8.2 5.4 22.6 41.1 34.9 34.9 3.8 14.7 6.6 31.2 64.1 18.5 35.0 22.0 6.0 0.8 9.5 0.7 6.8 11.2 6.0 20.2 14.6 32.0 5.1 0.0 1.5 0.0 3.0 3.3 5.1 1.3 1.2 1.6 5.3 2.0 1.0 2.9 0.2 2.9 0.0 3.0 0.0 2.1 59.8 32.7 12.7 27.9 61.5 43.4 65.1 23.6 34.5 35.4 50.6 300.1 34.7 3.9 3.3 4.0 2.9 35.7 9.4 23.9 0.0 5.9 2.0 0.0 12.5 52.9 9.3 13.7 0.0 59.1 53.1 9.3 26.0 5.8 153.5 29.3 25.4 24.8 41.7 97.6 68.6 3.4 8.2 55.6 17.2 15.7 11.8 21.6 2.9 1.4 3.8 4.7 0.0 4.4 0.9 1.1 1.9 14.5 5.2 16.8 3.5 SELENOS "AD-015, MGC2553, SBBI8, SELS, SEPS1, VIMP" ENSG00000131871 "Selenoprotein S" Q9BQE4 15 101270817-101277500 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 173.0;Exocrine glandular cells: 166.1;Extravillous trophoblasts: 174.9;Pancreatic endocrine cells: 185.9;Syncytiotrophoblasts: 254.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "plasmacytoid DC: 96.1" "Lineage enriched" "Detected in all" 5 "dendritic cells: 96.1" "Cell line enhanced" "Detected in all" "Karpas-707: 81.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010025 Approved Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA010025: AB_1079900" "unprognostic (1.90e-1)" "unprognostic (4.03e-2)" "unprognostic (1.06e-1)" "prognostic favorable (1.33e-4)" "unprognostic (2.42e-2)" "unprognostic (3.74e-3)" "unprognostic (3.18e-2)" "unprognostic (1.98e-1)" "unprognostic (9.83e-2)" "prognostic favorable (5.19e-4)" "unprognostic (2.42e-3)" "unprognostic (4.42e-1)" "unprognostic (1.11e-1)" "unprognostic (1.52e-1)" "unprognostic (1.67e-1)" "unprognostic (1.44e-1)" "unprognostic (2.66e-2)" 25.1 34.7 16.3 19.6 17.1 18.0 38.3 11.4 15.6 22.8 33.7 20.7 51.6 33.2 21.6 33.7 24.8 20.5 21.9 35.0 15.6 14.6 30.9 58.2 27.0 24.5 24.6 13.4 19.3 80.9 14.6 27.5 38.2 21.2 23.5 37.8 16.5 58.0 42.1 28.3 20.6 41.5 21.8 26.8 27.5 26.8 44.4 18.7 9.7 34.0 22.5 26.4 21.0 30.9 10.0 96.1 17.5 14.8 14.3 17.2 9.6 9.4 15.1 13.6 12.0 29.8 21.2 11.3 28.9 22.2 20.2 20.4 17.9 23.0 7.2 10.8 25.6 34.0 27.0 14.7 13.0 13.2 13.0 19.6 12.1 13.5 18.5 47.3 9.1 14.1 18.4 37.3 13.5 40.2 15.9 15.0 9.6 12.1 81.9 21.6 15.2 6.6 14.2 10.3 36.4 9.8 8.5 11.1 15.7 20.3 22.7 7.6 19.3 20.1 19.0 40.2 18.7 14.2 20.7 15.9 19.1 12.5 25.6 21.9 59.5 49.7 10.4 20.8 10.9 22.9 17.5 10.8 12.3 16.0 12.9 15.4 10.0 12.4 17.2 9.3 7.0 9.4 14.0 3.7 14.3 14.8 96.1 10.9 9.6 16.3 17.1 11.4 15.6 15.6 14.6 24.6 13.4 21.2 18.7 110.2 99.5 0.0 0.0 0.0 0.0 0.0 0.0 104.4 118.3 146.5 0.0 113.3 26.6 173.0 0.0 0.0 0.0 0.0 166.1 174.9 0.0 0.0 27.9 0.0 109.2 0.0 0.0 0.0 0.0 0.0 0.0 48.1 0.0 160.5 0.0 0.0 185.9 0.0 0.0 69.8 0.0 0.0 0.0 0.0 0.0 0.0 254.0 0.0 0.0 0.0 SLC27A3 "ACSVL3, FATP3, MGC4365" ENSG00000143554 "Solute carrier family 27 member 3" Q5K4L6 1 153774354-153780157 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ito cells: 131.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 5.9;granulocytes: 13.7;monocytes: 8.7" "Cell line enhanced" "Detected in many" "ASC diff: 35.6;HaCaT: 12.5;MCF7: 18.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA006935, HPA067508" Enhanced Enhanced "Endoplasmic reticulum" Yes No "Endoplasmic reticulum" "HPA006935: AB_1080003, HPA067508: AB_2685857" "unprognostic (1.88e-1)" "unprognostic (2.66e-2)" "unprognostic (1.34e-1)" "unprognostic (3.57e-2)" "unprognostic (2.70e-2)" "unprognostic (4.85e-2)" "unprognostic (6.08e-2)" "unprognostic (3.18e-2)" "unprognostic (4.22e-2)" "unprognostic (3.39e-2)" "prognostic favorable (5.23e-4)" "unprognostic (4.67e-2)" "prognostic unfavorable (6.33e-4)" "unprognostic (1.95e-1)" "unprognostic (4.41e-1)" "unprognostic (2.59e-1)" "unprognostic (2.08e-1)" 20.7 3.7 4.9 6.4 4.3 3.7 15.0 7.5 6.6 11.1 11.6 3.6 7.9 3.5 10.1 39.1 9.4 9.5 9.2 7.0 3.5 2.4 12.2 19.5 21.1 7.0 3.5 4.7 13.6 5.7 4.5 6.7 9.7 3.3 11.6 6.1 4.6 7.7 9.7 3.6 11.0 6.8 10.5 1.8 6.9 14.4 15.4 3.4 3.5 8.6 10.3 5.5 9.7 9.4 0.6 5.9 13.7 8.7 2.2 2.2 2.5 4.0 0.2 1.7 0.8 35.6 6.9 3.1 1.5 3.0 0.6 0.8 2.3 1.8 0.5 4.2 1.7 0.3 12.5 1.7 1.4 0.4 0.3 2.3 0.8 2.2 1.0 4.3 1.4 2.9 4.6 4.7 0.2 0.9 0.6 4.8 0.2 0.4 0.7 0.2 18.8 0.1 4.1 4.1 8.6 1.9 7.1 0.3 0.4 1.0 0.5 3.5 3.9 0.8 8.3 1.5 2.4 2.2 4.1 1.1 0.8 1.7 4.4 0.0 1.3 1.2 0.1 2.0 4.8 0.6 7.2 8.7 13.7 2.1 7.3 1.5 0.5 1.0 2.2 5.9 0.6 0.5 1.1 1.7 2.2 7.2 1.0 0.3 2.5 4.9 4.3 7.5 6.6 3.5 2.4 3.5 4.7 3.3 3.4 17.9 43.8 4.5 9.1 10.4 0.8 2.5 38.2 0.0 7.9 3.5 0.0 24.4 0.0 3.1 0.4 20.2 2.5 0.0 6.4 10.1 17.3 4.2 25.3 25.9 29.3 1.6 4.1 131.3 31.9 2.4 17.5 32.9 21.9 45.1 16.0 1.5 3.7 33.6 13.4 3.4 1.0 6.5 12.8 1.1 3.4 6.8 7.3 15.9 9.1 2.6 SOAT1 "ACAT, SOAT, STAT" ENSG00000057252 "Sterol O-acyltransferase 1" P35610 1 179293714-179358680 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 87.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009533, HPA047171" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB009533: AB_633499, HPA047171: AB_2679967" "unprognostic (3.29e-2)" "unprognostic (7.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.81e-3)" "unprognostic (7.81e-3)" "unprognostic (3.29e-1)" "unprognostic (9.00e-2)" "unprognostic (9.84e-2)" "unprognostic (1.06e-1)" "unprognostic (5.45e-3)" "unprognostic (7.02e-3)" "unprognostic (4.67e-3)" "unprognostic (9.64e-2)" "unprognostic (4.67e-2)" "unprognostic (1.82e-1)" 23.9 87.4 4.1 8.3 5.7 7.0 9.6 2.9 4.0 6.8 7.2 5.6 7.8 5.5 8.2 6.0 3.4 8.3 9.8 5.7 5.5 4.1 12.1 8.8 18.6 13.0 6.2 2.3 10.8 15.5 8.1 14.6 11.6 4.9 13.1 6.9 9.6 51.1 8.9 4.1 5.8 7.0 7.5 10.5 13.6 8.1 6.8 4.9 4.0 6.2 2.9 7.2 9.4 8.7 6.6 24.3 19.8 26.8 18.5 16.0 14.8 20.4 9.6 7.9 11.7 30.9 16.9 42.5 9.9 17.5 22.0 25.7 9.8 23.4 11.6 15.7 18.0 26.8 7.5 25.1 5.9 23.8 13.2 5.2 5.4 8.1 10.2 12.7 9.2 2.1 13.3 3.8 25.7 22.1 9.3 9.4 14.3 11.6 6.0 34.2 4.3 9.8 3.0 3.8 3.3 3.2 12.2 10.3 6.8 19.4 12.8 2.4 6.2 15.3 6.5 5.7 9.8 6.8 6.3 8.9 26.2 12.6 28.6 21.8 8.5 31.0 9.9 10.4 5.0 48.5 19.6 26.8 0.7 14.0 17.0 13.5 6.6 13.1 13.1 24.3 5.5 12.7 12.6 19.8 18.5 11.1 4.4 16.0 14.8 4.1 5.7 2.9 4.0 5.5 4.1 6.2 2.3 4.9 4.9 20.8 33.1 10.4 8.5 8.9 7.2 5.6 22.9 48.2 14.8 19.2 13.7 14.8 1.7 33.4 19.5 13.0 7.9 0.0 21.9 46.9 18.6 33.8 13.9 21.9 69.5 6.4 57.5 21.5 66.9 10.8 30.2 63.1 21.9 44.1 27.7 6.8 20.1 10.5 24.4 12.8 13.0 25.8 13.0 5.6 8.2 4.5 7.3 27.9 16.8 6.5 STIM1 "D11S4896E, GOK" ENSG00000167323 "Stromal interaction molecule 1" Q13586 11 3854527-4093210 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA011088, HPA012123, CAB037128, CAB037288" Enhanced Enhanced "Endoplasmic reticulum" NA NA 4900000 "Endoplasmic reticulum" "CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882" "unprognostic (2.06e-1)" "unprognostic (9.75e-2)" "unprognostic (1.34e-1)" "unprognostic (3.85e-3)" "unprognostic (3.13e-2)" "unprognostic (4.12e-1)" "unprognostic (3.43e-1)" "unprognostic (1.59e-1)" "unprognostic (2.25e-1)" "unprognostic (7.41e-2)" "unprognostic (1.86e-1)" "unprognostic (2.88e-2)" "unprognostic (9.35e-2)" "unprognostic (1.40e-1)" "unprognostic (2.73e-1)" "unprognostic (3.48e-2)" "unprognostic (1.39e-2)" 20.8 9.9 15.5 28.9 19.9 23.1 53.1 14.1 16.8 20.5 21.2 8.5 16.5 9.2 20.6 20.3 35.1 19.8 35.6 14.3 10.3 10.5 13.2 29.0 21.6 34.0 7.7 10.3 21.7 21.2 27.7 9.4 18.1 9.0 18.2 13.7 23.5 46.9 17.0 49.4 22.1 16.0 22.5 8.7 23.2 15.6 20.1 6.0 39.7 34.2 26.6 23.4 19.5 21.7 11.1 8.5 17.1 20.6 17.6 18.2 13.3 14.9 19.4 6.1 10.6 29.0 25.2 8.4 13.5 13.7 9.6 11.9 8.7 5.0 15.9 14.0 18.6 20.1 27.4 7.7 7.9 8.0 13.0 11.6 25.6 7.4 13.1 23.6 20.6 14.9 28.6 19.7 14.0 34.4 13.1 12.5 21.7 15.5 30.3 9.9 3.4 19.4 7.5 2.4 8.3 6.9 4.9 8.7 14.9 15.2 8.8 1.2 5.6 19.2 12.3 7.2 10.3 4.6 11.7 12.8 17.7 5.9 17.2 9.2 32.8 24.7 8.1 14.7 8.7 10.1 12.4 9.5 17.1 17.3 13.0 13.9 7.3 12.6 18.2 8.5 11.1 14.3 12.8 15.2 17.6 20.6 7.5 12.8 13.3 15.5 19.9 14.1 16.7 10.3 10.5 7.7 10.3 9.0 6.0 14.9 8.0 10.3 6.0 14.5 4.9 3.9 12.7 9.4 5.7 5.2 13.7 20.7 1.7 12.2 3.6 14.7 8.6 0.0 12.5 11.0 12.4 10.5 28.9 28.0 13.7 15.9 8.7 20.3 19.4 4.9 25.3 12.4 16.9 5.4 12.9 16.9 10.2 3.5 10.6 3.5 3.6 25.8 18.1 20.9 8.1 19.4 14.5 22.0 7.5 10.3 SYVN1 "DER3, HRD1" ENSG00000162298 "Synoviolin 1" Q86TM6 11 65121780-65134533 "Enzymes, Predicted membrane proteins" "Stress response, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 56.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005480, HPA024300, CAB037030" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum,Plasma membrane" NA NA Nucleoplasm "Endoplasmic reticulum, Plasma membrane" "CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.22e-1)" "unprognostic (2.17e-2)" "unprognostic (2.85e-2)" "prognostic favorable (6.88e-4)" "unprognostic (7.67e-2)" "unprognostic (2.50e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.77e-2)" "unprognostic (1.56e-2)" "unprognostic (4.89e-1)" "unprognostic (3.85e-2)" "unprognostic (1.16e-1)" 13.8 20.8 11.0 33.0 15.3 13.8 14.9 13.3 19.3 15.1 14.2 21.0 20.2 13.2 16.0 21.1 14.4 16.1 15.3 12.9 11.3 10.0 16.4 78.0 14.2 28.9 18.2 8.7 17.1 68.1 24.4 21.0 20.9 14.4 15.0 15.4 13.3 48.9 22.6 16.7 14.4 19.6 13.6 12.8 27.1 18.3 14.4 14.9 10.3 23.5 8.0 42.2 13.3 12.6 17.5 13.0 11.6 5.4 2.2 5.5 3.8 8.6 11.1 6.7 9.0 17.1 9.8 6.7 9.0 9.3 11.5 8.2 6.0 15.2 49.0 12.3 11.5 15.2 13.5 7.3 9.1 9.5 7.6 5.5 7.7 12.9 13.4 20.8 11.5 14.0 12.4 16.5 10.1 23.0 10.3 7.4 5.2 9.6 25.1 6.7 12.9 5.0 8.3 7.2 9.1 7.7 8.5 5.7 19.7 7.2 8.6 4.4 9.0 8.3 20.7 14.5 6.2 15.4 7.6 7.1 8.0 5.3 14.3 6.0 50.2 34.7 56.6 10.8 5.9 8.9 11.6 5.4 9.3 5.5 3.3 5.0 15.4 3.9 5.1 3.1 17.5 2.9 3.0 5.2 2.2 3.2 13.0 3.6 3.8 11.0 15.3 13.3 19.3 11.3 10.0 18.2 8.7 14.4 14.9 14.9 21.3 22.2 6.0 15.7 10.2 3.4 33.1 9.4 20.5 10.4 31.4 11.5 1.7 10.5 4.3 8.3 15.8 23.3 16.3 12.6 12.1 13.4 1.1 60.4 13.6 12.7 8.1 14.1 14.8 3.5 19.0 11.6 11.8 6.4 25.0 10.8 17.1 12.4 12.4 7.2 17.1 12.9 7.5 21.0 10.9 14.1 35.8 10.2 14.5 11.6 TCL1A TCL1 ENSG00000100721 "T cell leukemia/lymphoma 1A" P56279 14 95709967-95714196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "blood: 179.4;lymphoid tissue: 63.7" "Group enriched" "Detected in some" 5 "B-cells: 166.3;Spermatogonia: 48.5" "Cancer enriched" "Detected in many" 18 "testis cancer: 64.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 381 "memory B-cell: 45.6;naive B-cell: 179.4;plasmacytoid DC: 79.8" "Group enriched" "Detected in many" 487 "B-cells: 179.4;dendritic cells: 79.8" "Group enriched" "Detected in some" 157 "Daudi: 71.1;REH: 92.4;U-698: 94.4" "Not detected" "Not detected" "CAB004045, HPA016604" Enhanced Enhanced "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB004045: AB_2179419, HPA016604: AB_1857859" "unprognostic (1.27e-3)" "unprognostic (3.12e-4)" "unprognostic (2.61e-4)" "unprognostic (2.01e-2)" "unprognostic (1.27e-1)" "unprognostic (4.75e-4)" "unprognostic (7.70e-2)" "unprognostic (9.67e-3)" "unprognostic (1.03e-1)" "unprognostic (3.35e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-2)" "unprognostic (2.64e-2)" "unprognostic (1.87e-1)" "unprognostic (3.94e-1)" "unprognostic (2.06e-1)" "unprognostic (4.55e-1)" 0.4 0.2 0.2 53.4 0.2 4.8 0.3 0.2 0.2 0.2 0.9 0.0 0.2 0.0 0.3 0.0 0.8 0.3 0.6 0.3 0.2 0.2 1.1 0.4 3.2 63.7 0.2 0.0 0.3 0.2 0.0 0.2 0.6 0.0 0.4 0.2 0.1 2.9 0.0 0.2 0.2 10.4 0.1 0.2 33.5 0.5 5.3 0.0 4.7 0.8 1.2 53.6 3.6 0.3 179.4 79.8 0.2 0.1 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.5 94.4 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 45.6 0.0 0.0 0.1 179.4 0.1 0.0 0.2 0.0 0.1 79.8 0.0 6.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 2.2 166.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 20.6 48.5 0.0 0.0 0.0 0.0 0.0 TMEM230 "C20orf30, HSPC274" ENSG00000089063 "Transmembrane protein 230" Q96A57 20 5068232-5113103 "Predicted membrane proteins, Transporters" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009078, HPA061421" Uncertain Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA009078: AB_1078345, HPA061421: AB_2684513" "unprognostic (1.39e-1)" "unprognostic (3.61e-1)" "unprognostic (3.73e-1)" "unprognostic (1.28e-1)" "unprognostic (3.71e-2)" "unprognostic (9.67e-3)" "unprognostic (5.85e-3)" "unprognostic (4.34e-3)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "unprognostic (2.74e-1)" "unprognostic (4.07e-2)" "unprognostic (9.70e-2)" "unprognostic (2.31e-1)" "unprognostic (2.09e-1)" "unprognostic (2.84e-2)" "unprognostic (1.55e-2)" 40.0 40.4 34.3 17.1 27.9 15.6 80.9 20.2 44.8 35.7 29.9 23.2 33.3 18.7 30.2 39.0 26.0 27.4 31.4 49.7 32.7 36.1 44.6 81.0 32.9 49.2 41.1 23.1 31.5 53.5 22.4 31.5 21.8 25.8 33.8 27.9 27.4 26.8 31.0 32.4 10.6 29.4 28.1 44.3 20.6 25.8 24.0 16.4 18.8 42.5 24.9 22.2 31.5 18.9 45.6 44.7 30.5 49.2 39.1 48.2 78.3 33.3 23.5 30.9 23.2 70.0 62.5 23.6 27.1 40.8 26.8 29.7 18.5 33.4 16.0 22.3 39.1 30.6 27.8 22.9 40.4 38.9 17.8 26.3 28.3 7.3 56.8 44.8 32.7 11.8 43.1 45.2 20.5 41.3 37.5 35.2 35.8 26.4 44.4 43.8 9.5 32.9 30.6 23.5 64.2 33.6 21.4 20.7 34.3 40.2 17.2 26.1 31.7 16.3 34.3 56.3 34.8 27.4 31.3 29.5 34.9 20.4 33.4 29.0 29.7 58.9 31.3 14.0 28.3 36.5 28.4 48.1 30.5 39.3 49.2 48.2 45.6 43.1 41.9 44.7 37.9 45.0 44.3 15.6 39.1 46.1 43.8 38.6 78.3 34.3 27.9 20.2 44.8 32.7 36.1 41.1 23.1 25.8 16.4 53.6 61.3 129.3 107.8 62.5 93.4 47.8 94.3 64.3 48.9 146.5 60.9 146.0 426.1 129.1 144.0 103.4 53.5 46.7 97.3 172.4 154.3 157.7 111.9 118.4 189.6 58.8 91.9 120.3 153.8 67.6 196.5 153.1 189.0 263.3 96.8 65.8 86.4 119.7 207.2 284.9 89.9 84.1 143.4 110.9 90.6 52.9 123.8 145.1 112.1 128.5 TOR1AIP2 "IFRG15, LULL1, NET9" ENSG00000169905 "Torsin 1A interacting protein 2" "Q8NFQ8, Q9H496" 1 179839967-179877803 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051849, HPA058348, HPA070542" Uncertain Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA051849: AB_2681637, HPA058348: AB_2683687, HPA070542: AB_2686278" "unprognostic (1.22e-1)" "unprognostic (8.49e-3)" "unprognostic (2.61e-1)" "unprognostic (2.25e-2)" "unprognostic (2.15e-1)" "unprognostic (1.92e-2)" "unprognostic (4.35e-2)" "unprognostic (1.82e-1)" "unprognostic (6.17e-2)" "unprognostic (7.64e-3)" "unprognostic (3.06e-1)" "unprognostic (3.45e-1)" "prognostic unfavorable (2.29e-4)" "unprognostic (9.99e-2)" "unprognostic (1.05e-1)" "unprognostic (8.36e-2)" "unprognostic (1.36e-1)" 13.3 16.4 11.2 7.3 13.1 30.4 17.5 12.1 11.6 9.1 19.8 10.0 26.9 15.2 11.4 18.7 15.9 8.5 10.1 11.2 11.1 10.0 11.7 37.9 13.2 9.5 9.7 10.4 13.5 16.4 17.4 19.3 41.3 11.0 9.3 8.3 10.0 9.9 16.9 23.0 12.0 30.7 11.6 12.0 9.0 12.2 8.8 11.2 6.7 17.4 10.5 9.5 10.4 13.4 6.9 9.2 17.7 8.7 4.9 7.4 2.5 12.8 12.9 10.3 21.1 25.4 14.2 40.5 17.0 20.9 13.9 14.2 19.1 22.4 10.4 21.7 18.5 7.7 19.4 17.7 17.7 18.8 11.7 9.6 12.7 21.1 15.8 18.6 13.4 14.7 22.3 13.8 18.7 20.4 12.3 19.5 10.0 24.4 11.2 16.7 7.5 9.6 9.3 24.4 14.4 3.2 10.7 14.4 14.8 10.7 22.3 8.6 21.8 19.3 21.6 16.6 20.8 21.5 9.8 25.1 20.2 18.6 11.2 13.4 17.8 25.3 20.9 11.1 9.8 19.0 17.7 6.6 7.7 7.1 8.7 6.8 6.9 6.8 6.1 4.4 6.9 7.4 7.2 13.4 4.9 7.9 9.2 5.7 2.5 11.2 13.1 12.1 11.2 11.1 10.0 9.7 10.4 11.0 11.2 142.9 48.3 19.0 58.0 222.7 27.1 30.5 122.3 32.1 64.8 73.3 35.3 86.6 21.6 52.0 23.9 50.1 79.9 46.7 55.0 166.0 51.6 49.3 18.5 210.0 37.5 30.2 21.1 42.4 43.5 15.3 54.1 35.3 45.5 47.7 44.5 44.6 76.2 32.8 80.2 38.5 31.3 51.8 41.2 27.2 29.1 218.2 150.8 44.9 38.5 99.9 VAPA "hVAP-33, VAP-A" ENSG00000101558 "VAMP associated protein A" Q9P0L0 18 9914002-9960021 "Plasma proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009174 Approved Enhanced "Endoplasmic reticulum" NA NA 5300000 "Endoplasmic reticulum" "HPA009174: AB_1080549" "unprognostic (4.03e-2)" "unprognostic (7.47e-2)" "unprognostic (9.36e-2)" "unprognostic (5.20e-2)" "unprognostic (2.00e-1)" "unprognostic (2.99e-2)" "unprognostic (4.79e-3)" "unprognostic (1.80e-1)" "unprognostic (5.39e-2)" "unprognostic (6.80e-3)" "unprognostic (2.99e-2)" "unprognostic (8.11e-2)" "prognostic favorable (5.72e-7)" "unprognostic (1.03e-1)" "unprognostic (1.66e-1)" "unprognostic (1.23e-1)" "unprognostic (5.77e-2)" 27.5 64.8 28.8 21.0 35.5 73.5 27.4 32.9 39.4 24.9 34.3 30.7 19.3 27.8 30.8 23.8 42.3 27.9 29.4 39.9 28.0 30.2 32.7 33.2 35.1 24.6 33.4 28.8 40.6 36.5 25.0 19.4 35.2 48.1 25.2 32.7 18.0 27.9 21.8 55.4 27.6 32.3 28.5 39.1 27.7 34.0 25.2 28.8 36.3 36.4 28.3 22.9 36.0 30.2 24.5 30.6 62.5 37.3 22.2 24.6 39.7 17.3 10.5 12.7 8.3 15.0 16.3 17.8 21.5 17.9 19.6 21.6 14.1 17.3 17.1 20.1 18.8 17.0 12.2 12.3 20.5 22.5 10.6 15.4 27.8 11.2 21.7 35.7 37.5 53.4 15.3 20.8 18.5 22.1 15.4 19.8 14.0 28.0 17.9 17.1 9.3 28.8 21.8 8.2 59.8 16.8 15.1 17.3 23.1 19.1 17.5 18.0 9.8 24.9 15.2 15.4 12.2 14.2 19.4 21.1 32.0 23.8 33.1 26.1 32.1 26.0 20.4 18.1 16.2 21.9 26.1 37.3 62.5 19.3 32.4 22.7 24.5 20.3 20.7 30.6 22.7 22.2 20.4 59.2 22.2 26.4 21.8 24.6 39.7 28.8 35.5 32.9 39.4 28.0 30.2 33.4 28.8 48.1 28.8 119.1 156.9 129.2 289.0 598.2 103.5 201.2 160.5 211.5 124.0 197.1 58.9 238.9 388.0 249.4 7.6 182.0 272.4 70.0 315.1 261.3 247.0 278.9 222.5 128.2 255.8 128.7 138.8 187.9 265.3 9.5 168.5 232.2 264.9 418.4 154.5 119.8 283.7 174.6 203.3 294.2 76.5 187.5 270.9 168.9 212.6 544.1 378.5 153.4 155.5 360.2 VAPB "ALS8, VAP-B, VAP-C" ENSG00000124164 "VAMP associated protein B and C" O95292 20 58389122-58451101 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Unfolded protein response" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013144, CAB013722" Supported Enhanced "Endoplasmic reticulum" NA NA 220000 "Endoplasmic reticulum" "CAB013722: , HPA013144: AB_1858717" "unprognostic (3.28e-3)" "unprognostic (3.88e-2)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" "unprognostic (9.36e-2)" "unprognostic (3.15e-2)" "unprognostic (4.76e-3)" "unprognostic (2.80e-1)" "unprognostic (4.47e-2)" "unprognostic (8.06e-3)" "unprognostic (3.11e-2)" "unprognostic (2.99e-1)" "prognostic favorable (1.08e-8)" "unprognostic (1.05e-1)" "unprognostic (5.31e-1)" "unprognostic (6.34e-3)" "unprognostic (2.99e-2)" 17.4 31.1 21.8 12.6 24.3 4.8 13.2 16.5 31.8 11.7 16.1 17.0 13.3 22.5 13.0 13.1 14.8 13.7 12.7 24.5 21.4 22.1 21.8 23.5 13.6 10.4 23.2 25.1 17.7 15.5 28.5 16.3 11.1 31.6 15.0 12.1 11.4 17.9 15.7 46.8 15.3 20.6 15.2 24.9 11.4 14.7 9.4 15.8 6.7 26.7 18.8 9.4 11.6 18.5 5.6 4.3 6.8 5.2 6.6 9.5 4.6 10.9 11.0 12.4 6.6 11.4 4.8 11.0 9.8 4.1 15.2 7.5 44.3 10.6 9.7 14.1 6.6 12.1 21.0 9.8 14.1 9.1 4.5 7.4 5.8 12.2 13.9 11.5 5.4 7.4 10.9 16.4 8.4 7.0 7.4 7.5 9.7 13.7 5.5 7.3 34.4 8.5 10.8 6.5 21.5 14.6 8.6 11.5 6.3 11.6 14.7 17.5 12.1 16.2 43.2 16.9 7.1 17.7 8.3 10.3 24.6 12.0 12.3 13.1 7.4 7.9 11.1 20.8 6.0 12.4 3.9 4.4 5.2 7.8 4.4 9.1 5.6 9.0 6.2 4.3 4.7 6.7 9.5 6.8 6.6 5.2 4.3 5.0 4.6 21.8 24.3 16.5 31.8 21.4 22.1 23.2 25.1 31.6 15.8 41.7 23.2 11.7 12.1 10.4 26.4 43.1 25.5 18.7 13.6 29.6 27.5 28.5 29.9 29.7 4.2 20.4 30.7 0.0 26.6 42.2 18.8 15.2 9.2 32.1 14.0 33.4 20.8 14.7 14.0 5.1 17.3 13.9 13.5 24.4 22.3 34.0 29.0 19.2 23.7 31.6 29.2 12.9 20.5 20.4 28.3 9.3 37.2 18.7 24.2 13.6